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1 Executive summary 
 
This report presents the findings of a systematic review of systematic reviews commissioned by the 
NICE Centre for Public Health to support the development of updated guidance on tuberculosis. This 
review is designed to supplement the review of interventions to increase the uptake of BCG 
vaccination for TB (published separately), and should be read in conjunction with that review. 
The review question is: 
 What is known from systematic reviews about the effectiveness and cost-effectiveness of 
interventions to improve the uptake of vaccinations? 
We used a brief systematic review methodology (along the lines of a Rapid Evidence Assessment), 
with limited database searching covering the dates 2003-2013. We included any systematic review 
which reported data on the effectiveness and/or cost-effectiveness of interventions to improve the 
uptake of any vaccination in a high-income (OECD) country. Quality assessment and data extraction 
were carried out using standardised forms from the NICE methods manual. Data were synthesized 
narratively. 
Twenty-seven reviews were included in the review. Most reviews were graded medium (+) or high 
(++) quality. A wide range of intervention types were included. The findings of the reviews are 
summarised in the evidence statements below. Where sufficient pooled analyses are reported, the 
effect sizes are characterised in the evidence statements as small, medium or large using the 
following heuristic: 
 small: OR 1-1.25 
 medium: OR 1.25-2 
 large: OR >2 
 
Evidence statement 1: Reminders and recall to increase uptake of vaccinations 
There is strong evidence from seven reviews (Free et al., 2013 (++); Jacobson Vann and Szilagyi, 2009 
(++); Lau et al., 2012 (++); Ndiaye et al., 2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 
(++); Williams et al., 2011 (++)) that recall and reminder interventions, including letters, telephone 
calls and text messages, are effective in increasing the uptake of a range of vaccinations. Three 
meta-analytic reviews (Jacobson Vann and Szilagyi, 2009 (++); Lau et al., 2012 (++); Thomas et al., 
2010b (++)) show that these interventions have a medium to large effect size. There is evidence that 
these interventions are effective both for adults and older people (Jacobson Vann and Szilagyi, 2009 
(++); Lau et al., 2012 (++); Thomas et al., 2010b (++)) and for parents of young children (Jacobson 
Vann and Szilagyi, 2009 (++)). There is some suggestion from one review (Tuckerman et al., 2009 (++) 






The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There are no obvious limits to the applicability of this evidence, 
although the different context of healthcare service organisation may affect the delivery of 
interventions. 
 
Evidence statement 2: Patient education to increase uptake of vaccinations 
There is mixed evidence from five reviews (Lau et al., 2012 (++); Moxey et al., 2003 (–); Ndiaye et al., 
2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++)) on the effectiveness of patient 
education interventions (other than reminders) in promoting the uptake of vaccination. One review 
(Lau et al., 2012 (++)) finds community media campaigns to be effective, with medium to large effect 
size. The findings on health education for patients or parents of young children are mixed. 
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. This may limit the applicability of the findings, due to cultural or 
other differences. 
 
Evidence statement 3: Incentives or disincentives for patients to increase uptake of vaccinations 
There is mixed evidence from five reviews on the effectiveness of incentives or disincentives for 
promoting the uptake of vaccinations (Lagarde et al., 2009 (+); Lau et al., 2012 (++); Ndiaye et al., 
2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++)). There is some evidence from two 
reviews that providing free vaccines is effective (Lau et al., 2012 (++); Thomas et al., 2010b (++)). 
There is some evidence from two reviews (Lau et al., 2012 (++); Ndiaye et al., 2005 (++)) suggesting 
that cash incentives may be effective. The evidence on conditional cash transfers (Lagarde et al., 
2009 (+)) and penalties for welfare recipients (Tuckerman et al., 2009 (++)) is inconclusive. 
Applicability 
There are potential limits to the applicability of this evidence: for example the provision of free 
vaccines is of limited relevance to the UK context; the evidence on conditional cash transfers is from 
Mexico, a middle-income country; and the evidence on welfare penalties is from the USA, and may 
represent a different policy context. 
 
Evidence statement 4: Home visiting and lay health worker interventions to increase uptake of 
vaccinations 
There is strong evidence from four reviews (Glenton et al., 2011 (++); Lewin et al., 2010 (+); Thomas 
et al., 2010b (++); Tuckerman et al., 2009 (++)) that home visiting and lay health worker 
interventions are effective in increasing the uptake of vaccination. Home visiting has been found to 




2010 (+); Tuckerman et al., 2009 (++)) and for older people (Thomas et al., 2010b (++)), although 
effect sizes are small. However, there is evidence from three reviews that home visiting 
interventions are ineffective for parents who use drugs or alcohol (Kaufman et al., 2013 (++); 
Tuckerman et al., 2009 (++); Turnbull and Osborn, 2012 (++)), and mixed evidence from one review 
for parents at risk for child abuse or neglect (Selph et al., 2013 (+)).  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with few or no studies 
from the UK. There may be limits to the applicability of this evidence resulting from the different 
cultural, policy or demographic contexts. 
 
Evidence statement 5: Community engagement to increase uptake of vaccinations 
There is strong evidence from two reviews (Lau et al., 2012 (++); Tuckerman et al., 2009 (++)) that 
community engagement interventions, including outreach to at-risk groups and information or case 
management, are effective in increasing the uptake of vaccinations. These interventions appear to 
be effective for the general adult population (Lau et al., 2012 (++)) and for disadvantaged parents 
(Tuckerman et al., 2009 (++)).  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence resulting 
from the different cultural, policy or demographic contexts. 
 
Evidence statement 6: Health checks and well-child clinics to increase uptake of vaccinations 
There is mixed evidence from one review (Boulware et al., 2006 (++)) on the effectiveness of routine 
health checks in increasing vaccination uptake. There is medium evidence from one review (Coker et 
al., 2013 (+)) that well-child clinics, i.e. specialist preventive services for parents of young children, 
are effective in increasing vaccination uptake. 
Applicability 
There is limited information on the country and context of the studies included in this category, and 
most appear to be in the USA. There may be limits to the applicability of this evidence to the UK 
resulting from the different contexts of health service delivery. 
 
Evidence statement 7: school-based interventions to increase uptake of vaccinations 
There is medium evidence from one review (Tuckerman et al., 2009 (++)) that policies requiring 
children to be vaccinated in order to attend school or day care is effective in increasing the uptake of 





The majority of the evidence in this review appears to come from the USA, with no evidence from 
the UK. There may be limits to the applicability of this evidence to the UK resulting from the 
different contexts in terms of educational policy. 
 
Evidence statement 8: national vaccination programmes to increase uptake of vaccinations 
There is medium evidence from one review (Tuckerman et al., 2009 (++)) that national vaccination 
programmes, including policy changes and promotion and education campaigns, increase the uptake 
of childhood vaccinations. 
Applicability 
The evidence in this review comes from Australia and Finland, with no evidence from the UK. There 
may be limits to the applicability of this evidence due to the different cultural or policy contexts. 
 
Evidence statement 9: Reminders to clinicians to increase uptake of vaccinations 
There is strong evidence from six reviews (Arditi et al., 2012 (+); Holt et al., 2012 (++); Lau et al., 
2012 (++); Ndiaye et al., 2005 (++); Shojania et al., 2011 (++); Tuckerman et al., 2009 (++)) that 
reminders to clinicians are effective in increasing vaccination uptake. However, two reviews report 
more mixed findings (Souza et al., 2011 (++); Thomas et al., 2010b (++)). Two meta-analytic reviews 
(Holt et al., 2012 (++); Lau et al., 2012 (++)) show medium to large effect sizes.  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence due to the 
different contexts of health service delivery. 
 
Evidence statement 10: Incentives and bonus payments to providers to increase uptake of 
vaccinations 
There is medium evidence from six reviews (Eijkenaar et al., 2013 (–); Houle et al., 2012 (+); Lau et 
al., 2012 (++); Scott et al., 2011 (+); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++)) that 
incentives and bonus payments to clinicians or practices, such as pay-for-performance schemes or 
payments per vaccination carried out, is likely to increase vaccination uptake. Two meta-analytic 





The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence to the UK 
resulting from the different policy contexts and healthcare funding systems. 
 
Evidence statement 11: Clinician education to increase uptake of vaccinations 
There is mixed evidence from five reviews (Lau et al., 2012 (++); Ndiaye et al., 2005 (++); Thomas et 
al., 2010b (++); Tuckerman et al., 2009 (++); Williams et al., 2011 (++)) regarding clinician education 
programmes to promote vaccination. Two reviews indicate that clinician education does not have a 
significant effect (Ndiaye et al., 2005 (++); Williams et al., 2011 (++)), one indicates that it is effective 
(Tuckerman et al., 2009 (++)), and one shows mixed findings (Lau et al., 2012 (++)). One review 
(Thomas et al., 2010b (++)) indicates that facilitators working with clinical practices may be effective 
in increasing vaccination uptake. 
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There are no obvious limits to the applicability of this evidence. 
 
Evidence statement 12: Audit and feedback to increase uptake of vaccinations 
There is mixed evidence from five reviews (Lau et al., 2012 (++); Ndiaye et al., 2005 (++); Thomas et 
al., 2010b (++); Tuckerman et al., 2009 (++); Williams et al., 2011 (++)) regarding the effectiveness of 
clinical audit and feedback interventions on the uptake of vaccination. Two reviews suggest that 
these interventions are effective (Ndiaye et al., 2005 (++); Tuckerman et al., 2009 (++)), while the 
findings of the other three are mixed (Lau et al., 2012 (++); Thomas et al., 2010b (++); Williams et al., 
2011 (++)).  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence resulting 
from the different contexts of clinical practice. 
 
Evidence statement 13: Changes to service delivery models to increase uptake of vaccinations 
There is strong evidence from three reviews (Lau et al., 2012 (++); Ndiaye et al., 2005 (++); 
Tuckerman et al., 2009 (++)) that a range of changes to service delivery are effective in increasing 
vaccination uptake. One review (Lau et al., 2012 (++)) shows that delivering vaccination services in 
alternative sites (such as patients’ homes or worksites or community pharmacies), and changing the 
team involved in delivering services (e.g. training nurses to give vaccinations) are both effective, with 
medium to large effect sizes. One review shows that group visits for people with chronic diseases are 




2012 (++)). One review shows that increasing clinic accessibility (e.g. extended opening hours) in 
conjunction with education or reminders is effective (Ndiaye et al., 2005 (++)). One review finds that 
opportunistic vaccination policies are effective in hospitals and prisons, but not in GP services 
(Tuckerman et al., 2009 (++)). The findings on hospital vaccination policies are mixed (Ndiaye et al., 
2005 (++); Tuckerman et al., 2009 (++)).  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence resulting 
from the different health system or demographic contexts. 
 
Evidence statement 14: Programmes to increase uptake of vaccinations among healthcare workers 
There is mixed evidence from five reviews (Burls et al., 2006 (+); Jordan et al., 2004 (+); Lam et al., 
2010 (++); Ndiaye et al., 2005 (++); Thomas et al., 2010a (+)) regarding the effectiveness of multi-
component interventions, generally combining education and changes to vaccination service 
delivery, to increase the uptake of vaccination among healthcare workers. These reviews find that 
although most studies show some positive direction of effect, in most cases it does not attain 
significance.   
Applicability 
The evidence in these reviews appears to come from a range of countries, with relatively little 
evidence from the UK. There may be limits to the applicability of this evidence resulting from the 







This review of reviews is intended to support the separate review of primary study evidence on 
interventions to promote the uptake of BCG vaccination for TB. For further details and background, 
please refer to the report for that review.  
This review covers review-level (secondary) evidence on all interventions to promote the uptake of 
any vaccination. By their nature, reviews of reviews cannot give a fully detailed and comprehensive 
picture of the primary evidence. Rather, the purpose of this review is to provide indicative 
information for the guideline development process on what is known about interventions to 
promote vaccination in disease areas other than TB. 
3 Methods 
This review was conducted according to the methods guidance set out in the current (third) edition 
of Methods for the development of NICE public health guidance. However, while the review process 
was systematic throughout, and designed to minimize bias as far as possible, fully comprehensive 
searches were not conducted for this review. 
3.1 Review question 
The review question is: 
 What is known from systematic reviews about the effectiveness and cost-effectiveness of 
interventions to improve the uptake of vaccinations? 
3.2 Searching 
The search strategy focused on key healthcare sources and reviews published within the last 10 
years (on the basis that restricting to recent reviews allows indirect access to older primary data). 
The following database sources were searched in June 2013, with a date limit of 2003-current: 
 MEDLINE via OVID; 
 MEDLINE in Process via OVID; 
 EMBASE via OVID; and 
 The Cochrane Library (CDSR, HTA and DARE) via www.thecochranelibrary.com 
A filter was used to restrict the searches to studies of human populations. No language restriction 
was applied. The search strategy took the following form: (vaccination) AND (review filter). See 
Appendix 1 for full details of the database search strategy. 
PROSPERO was also searched to identify any in-process unpublished reviews. 
The following web-sites were searched: 
 NICE (www.nice.org.uk); 
 Public Health Observatory (www.apho.org.uk); and 
 Public Health England (www.gov.uk/government/organisations/public-health-england) 






EPPI-Reviewer 4 software was used to manage data. A random sample of 10% of titles and abstracts 
were screened by two reviewers independently and differences resolved by discussion. Agreement 
for this initial stage of abstract screening was 97.0%, with kappa = 0.78. This was deemed to be 
adequate to ensure reliability, and the remaining 90% of titles and abstracts were screened by one 
reviewer alone. 
The full texts of all reviews which met the criteria, or where it was unclear whether they met the 
criteria, were retrieved and screened to the same criteria by two reviewers independently, with 
differences resolved by discussion. 
The inclusion criteria were as follows: 
1) Does the study report data on vaccination / immunization to prevent disease in humans? (The 
following were excluded: studies of vaccines used for immunotherapeutic treatment of disease; 
animal studies; studies of epidemiology or prevalence intended to inform vaccination programmes, 
but which do not report actual data regarding vaccination.) 
2) Is the study a systematic review (i.e. does it report at least some information on both search 
strategy and inclusion criteria)? 
3) Does the review include some data from high-income countries (OECD member)? 1 
4) Does the review include some data on the effectiveness and/or cost-effectiveness of interventions 
to improve the uptake of vaccination? (The following data types were excluded: descriptive data on 
rates of uptake, or determinants of uptake; data on the clinical effectiveness of vaccines themselves; 
data about views or beliefs regarding vaccination.) 
5) Was the review published in 2003 or later? 
As described below, subsequent to the application of these criteria a minimum quality threshold was 
applied based on the quality assessment tool in the methods manual. 
3.4 Quality assessment, data extraction and synthesis 
Review quality was assessed, and data extracted, using the tools in the methods manual (NICE, 
2012). Quality assessment and data extraction were conducted by two reviewers independently, 
with differences resolved by discussion. 
Following the completion of quality assessment, we decided to implement a further inclusion 
criterion, based on the fourth question of the quality assessment tool, which asks whether primary 
study quality was assessed by the review authors. Thus: 
6) Was any form of quality assessment carried out within the review? 
                                                          
1 These are: Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, 
France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Luxembourg, Mexico, 
Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, 




 Data were synthesized narratively by type of intervention. 
4 Results 
4.1 Flow of literature through the review 
Twenty-six reviews were included. Figure 1 shows the flow of literature through the review. 





4.2 Quality of the included reviews 
Table 1 shows the quality ratings assigned to the included reviews by the quality assessment tool. An 
example of the completed tool is in Appendix 4. It should be noted that as Q2 and Q4 relate closely 
to the screening criteria (viz., criteria (4) and (6) respectively), the answer is ‘yes’ for all studies. It 
should also be noted that the tool reflects the relevance of the review to our question as much as 
the objective quality of the reviews, so methodologically similar reviews may receive different 
ratings if one is more relevant than the other. 
Table 1. Quality of the included reviews 
 Q1 (RQ) Q2 (study 
type) 




Arditi et al., 
2012 
N Y Y Y Y + 
Boulware et 
al., 2006 
Y Y Y Y Y ++ 
Burls et al., 
2006 
Y Y ? Y N + 
Coker et al., 
2013 
N Y ? Y Y + 
Eijkenaar et 
al., 2013 
N Y Y Y N – 
Free et al., 
2013 
Y Y Y Y Y ++ 
Glenton et 
al., 2011 
Y Y Y Y Y ++ 
Holt et al., 
2012 
Y Y Y Y Y ++ 
Houle et al., 
2012 




Y Y Y Y Y ++ 
Jordan et al., 
2004 
Y Y Y Y N + 
Kaufman et 
al., 2013 
Y Y Y Y Y ++ 
Lagarde et 
al., 2009 
N Y Y Y Y + 
Lam et al., 
2010 
Y Y Y Y Y ++ 
Lau et al., 
2012 
Y Y Y Y Y ++ 
Lewin et al., 
2010 
N Y Y Y Y + 
Moxey et al., 
2003 
N Y N Y N – 
Ndiaye et al., 
2005 
Y Y Y Y Y ++ 





Selph et al., 
2013 
Y Y ? Y Y + 
Shojania et 
al., 2011 
? Y Y Y Y ++ 
Souza et al., 
2011 
? Y Y Y Y ++ 
Thomas et 
al., 2010a 
N Y Y Y ? + 
Thomas et 
al., 2010b 
Y Y Y Y Y ++ 
Tuckerman et 
al., 2009 
Y Y Y Y Y ++ 
Turnbull and 
Osborn, 2012 
Y Y Y Y Y ++ 
Williams et 
al., 2011 
Y Y Y Y Y ++ 
Key: ‘Y’=yes; ‘N’=no; ‘?’=unclear 
4.3 Populations included in the review 
The reviews have various foci with respect to the populations included. The majority of the 
interventions attempt to increase vaccination uptake either among infants and children, by targeting 
parents, or among older people. Five reviews explicitly focus on increasing childhood vaccinations 
(Coker et al., 2013 (+); Glenton et al., 2011 (++); Kaufman et al., 2013 (++); Lewin et al., 2010 (+); 
Williams et al., 2011 (++)), and one on older people (Thomas et al., 2010b (++)), but most data refer 
to these populations even where there is no explicit review-level population focus.  
Four reviews focus on healthcare workers (Burls et al., 2006 (+); Jordan et al., 2004 (+); Lam et al., 
2010 (++); Thomas et al., 2010a (+)); these form a separate body of evidence and have been 
considered on their own in the results section. 
Four reviews focus on more specific populations: one on parents who use alcohol or drugs (Turnbull 
and Osborn, 2012 (++)); one on parents at risk for child abuse or neglect (Selph et al., 2013 (+)); one 
on a range of populations considered to be ‘high-risk’, including people with chronic illnesses, 
injecting drug users, prisoners and others (Ndiaye et al., 2005 (++)); and one which considered 
evidence on the general population of children but focused within that on population inequalities, 
presenting evidence on a range of populations including low-SES and minority ethnic groups 
(Tuckerman et al., 2009 (++)).   
4.4 Types of interventions included in the review 
The interventions included in the review have been divided into three broad types. First, patient-
focused interventions are those delivered primarily to the population being vaccinated, to encourage 
them to be vaccinated. Second, provider-focused interventions are those delivered primarily to the 
healthcare workers providing vaccination services, to encourage them to provide more vaccination 
or to improve the accessibility of services for the population. Third, interventions aiming to increase 
vaccination uptake among healthcare workers form an intermediate category, in that they can be 
seen as combining aspects of both patient- and provider-focused interventions; these have been 




The more specific intervention types are set out in Table 2. 
Table 2. Intervention categories and references 
Patient-focused Reminders and recall 
Patient education 
Incentives and disincentives 
Home visiting / lay health workers 
Community engagement 
Health checks / well-child clinics 
School-based interventions 
Provider-focused Reminders to clinicians 
Incentives and bonus payments 
Clinician education 
Audit and feedback 
Changes to service delivery 
Healthcare workers Programmes for healthcare workers 
 
The following sections set out the evidence for each intervention type. For each result, the number 
of primary studies informing the result are listed (or ‘N NR’ if this is unclear). The designs of the 
primary studies are also shown, using the following abbreviations: 
 RCT: randomised controlled trial (including cluster-RCTs) 
 nRCT: non-randomised controlled trial 
 BA: before-after (one-group) study 
Other study designs have been reported where reviews use a different classification scheme 
(specifically interrupted time series (ITS) and cohort studies). 
Where the reviews reported pooled effect sizes (i.e. where they conducted a meta-analysis), the 
overall result of this has been reported from the review authors’ analyses. This may take the form of 
an odds ratio (OR), a relative risk (RR) or a median effect size; 95% confidence intervals for ORs and 
RRs, and interquartile ranges for median effect sizes, are reported where available in the review 
reports. Where sufficient pooled analyses are reported, the effect sizes are characterised in the 
evidence statements as small, medium or large using the following heuristic: 
 small: OR 1-1.25 
 medium: OR 1.25-2 
 large: OR >2 
If no pooled effect size is reported for a review, the overall direction of effect across each review’s 
included studies has been characterized qualitatively as positive, negative, mixed or inconclusive 
(effect sizes for the individual primary studies are not reported).  
The specific vaccination type considered is also listed, as far as possible. Standard abbreviations are 




4.5 Patient-focused interventions 
4.5.1 Reminders and recall  
Seven reviews (Free et al., 2013 (++); Jacobson Vann and Szilagyi, 2009 (++); Lau et al., 2012 (++); 
Ndiaye et al., 2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++); Williams et al., 2011 
(++)) investigated the effectiveness of reminders for people to attend vaccination appointments. 
Overall, most reviews show these interventions to be effective in increasing the uptake of 
vaccination. 
Free (2010 (++)) found one study showing that SMS (text message) reminders are effective in 
increasing uptake of hepatitis A and B vaccination amongst persons over 18 in travel clinics (1 nRCT, 
RR 1.19 (1.15-1.23)). 
Jacobson Vann and Szilagyi (2009 (++)) focused on the effectiveness of patient reminder and recall 
interventions, finding that such interventions are effective overall in increasing vaccination rates or 
numbers of people up-to-date with vaccinations (34 RCTs, OR 1.57 (1.41-1.75)). Subgroup analysis 
showed that these interventions were effective for childhood influenza vaccination (4 RCTs, OR 2.18 
(1.29-3.70)), routine childhood vaccination (15 RCTs, OR 1.47 (1.28-1.68)), adult influenza 
vaccination (12 RCTs, OR 1.66 (1.31-2.09)), and adult pneumococcus, tetanus, and Hepatitis B (3 
RCTs, OR 2.19 (1.21-3.99)), but not for adolescent vaccinations (1 RCT, OR 1.14 (0.98-1.31)). (It 
should be noted that most of the studies on adults concerned older people (over-65s) and/or people 
with chronic illness.) Subgroup analysis by type of intervention found that reminders by telephone 
were the most effective.  
Thomas et al. (2010b (++)) focused on reminder interventions for older people aged 60 or over living 
in the community. This review found that tailored letters or phone calls were effective in increasing 
influenza vaccination rates compared to no intervention (13 RCTs, OR 1.53 (1.33-1.76)), but that 
generic (i.e. non-tailored) reminders were only borderline significantly effective (11 RCTs, OR 1.21 
(0.99-1.48)).  
Lau et al. (2012 (++) also found reminders to be effective, with positive effects for both telephone 
reminders (N NR, OR 2.74 (1.23-6.12) for influenza and OR 2.86 (2.31-3.56) for pneumococcal illness) 
and mailed print materials (N NR, OR 1.45 (1.30-1.61) for influenza and OR 1.66 (1.59-1.74) for 
pneumococcal illness).  
Ndiaye et al. (2005 (++)) found one study of reminders in a primary care setting, which found them 
to be effective in increasing influenza vaccination amongst ‘high-risk’ patients (1 RCT). (No further 
information is given on how ‘high-risk’ was defined.) They also found five studies of patient 
reminders combined with provider reminders in primary care settings, most of which showed some 
positive change (median +3.7%), although significance appears to have been attained in only two of 
seven comparisons (2 RCT, 1 nRCT, 2 BA). Of the five studies, two examined influenza vaccination 
rates, two examined influenza and pneumococcal vaccination rates and one examined hepatitis B 
vaccination (in chronic haemodialysis patients).  
Tuckerman et al. (2009 (++)) found mixed evidence for reminder and recall interventions for parents 
of young children. Of three RCTs specifically focusing on low-income families, one found a significant 




increase for DTP, OPV and MMR vaccinations. They also found one RCT of reminders to parents or 
carers sent by pre-schools, which showed a significant positive effect for MMR and the DTP booster, 
and two of verbal reminders to parents of children admitted to hospital, which show mixed results 
for a range of childhood vaccinations (2 nRCTs). Four further studies with a specific focus on the 
MMR vaccine also found mixed results (3 RCTs, 1 BA). This review also found eight cost-effectiveness 
studies of reminder and recall interventions, covering a range of vaccine types (MMR, DTP, OPV, Hib, 
Hep B), but this evidence was inconclusive as the studies only took a healthcare provider perspective 
and did not consider the effectiveness of vaccines in preventing disease.  
Williams et al. (2011 (++)) focused on parents of children under 5 years old, and report mixed 
findings on reminder interventions. Across 22 studies (19 RCTs, 3 nRCTs), 14 of 41 intervention arms 
showed a significant effect, with a median increase in vaccination rates across the studies of 11%. 
The vaccination types included in these studies were varied, but included DTP, OPV, MMR and Hib. 
 
Overall, three substantial meta-analytic reviews of RCTs show reminder and recall interventions to 
be effective, with ORs of 1.57 (1.41-1.75) (Jacobson Vann and Szilagyi, 2009 (++)), 1.53 (1.33-1.76) 
(tailored reminders (Thomas et al., 2010b (++)), 1.21 (0.99-1.48) (generic reminders (Thomas et al., 
2010b (++)), 2.74 (1.23-6.12) (telephone, influenza (Lau et al., 2012 (++)), 2.86 (2.31-3.56) 
(telephone, pneumococcal (Lau et al., 2012 (++)), 1.45 (1.30-1.61) (print, influenza (Lau et al., 2012 
(++)) and 1.66 (1.59-1.74) (print, pneumococcal (Lau et al., 2012 (++)). Some of the other reviews 
report more mixed findings (Tuckerman et al., 2009 (++); Williams et al., 2011 (++)), but neither of 
the latter report pooled effect sizes, and so cannot readily be compared; possibly they appear more 
mixed simply because a pooled meta-analysis was not carried out. There is also some difference in 
populations, as the latter both focus on childhood vaccinations, while Thomas et al. (2010b (++)) and 
Lau et al. (2012 (++)) focus on adults. However, Jacobson Vann and Szilagyi (2009 (++)) do find 
reminder and recall interventions to be effective for routine childhood vaccinations.  
The majority of studies focus either on universal childhood vaccinations or on adult influenza or 
pneumococcal vaccination. Hence, their applicability to the TB context may be limited. The limited 
findings on socio-economically disadvantaged populations (Tuckerman et al., 2009 (++)) are more 
mixed than those reported for general-population samples. This may suggest that recall and 
reminder interventions are less effective for disadvantaged groups, although the evidence is not 
conclusive. 
Evidence statement 1: Reminders and recall to increase uptake of vaccinations 
There is strong evidence from seven reviews (Free et al., 2013 (++); Jacobson Vann and Szilagyi, 2009 
(++); Lau et al., 2012 (++); Ndiaye et al., 2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 
(++); Williams et al., 2011 (++)) that recall and reminder interventions, including letters, telephone 
calls and text messages, are effective in increasing the uptake of a range of vaccinations. Three 
meta-analytic reviews (Jacobson Vann and Szilagyi, 2009 (++); Lau et al., 2012 (++); Thomas et al., 
2010b (++)) show that these interventions have a medium to large effect size. There is evidence that 
these interventions are effective both for adults and older people (Jacobson Vann and Szilagyi, 2009 
(++); Lau et al., 2012 (++); Thomas et al., 2010b (++)) and for parents of young children (Jacobson 
Vann and Szilagyi, 2009 (++)). There is some suggestion from one review (Tuckerman et al., 2009 (++) 






The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There are no obvious limits to the applicability of this evidence, 
although the different context of healthcare service organisation may affect the delivery of 
interventions. 
4.5.2 Patient education 
Five reviews investigated educational or informational interventions for patients, other than 
reminders (Lau et al., 2012 (++); Moxey et al., 2003 (–); Ndiaye et al., 2005 (++); Thomas et al., 2010b 
(++); Tuckerman et al., 2009 (+)). Overall, these reviews show mixed results. 
Lau et al. (2012 (++)) report findings for several educational interventions. They found community 
media campaigns to be effective (N NR, OR 3.16 (1.35-7.37) for influenza and OR 1.31 (1.28-1.55) for 
pneumococcal illness); limited information is available on the content of these interventions, but 
most involved advertising or other exposure in broadcast and/or print media, and sometimes other 
formats such as posters and brochures. More mixed but potentially promising results were found for 
posters in waiting rooms or examination rooms (N NR, OR 1.78 (0.53-6.01) for influenza and OR 1.92 
(1.09-3.40) for pneumococcal illness) and for brochures at office visits (N NR, OR 1.38 (0.82-2.33) for 
influenza and OR 5.86 (3.29-10.44) for pneumococcal illness). The findings on outreach by 
emergency medical technicians were very mixed (N NR, OR 0.67 (0.01-36.06) for influenza and OR 
8.65 (0.02-4899.87) for pneumococcal illness).  
Moxey et al. (2003 (–)) focused on how information is provided to patients. They found one RCT 
indicating that ‘positively framed’ information (i.e. information emphasizing the benefits of being 
vaccinated) is no more effective than standard information in increasing influenza vaccination 
uptake rates (full outcome data are not reported).  
Ndiaye et al. (2005 (++)) found two studies of education for hospital patients, both of which showed 
a positive effect, one on hepatitis B and one on pneumococcal vaccination (2 RCTs).  
Thomas et al. (2010b (++)), focusing on people aged 60 or over, found some evidence for the 
effectiveness of nurse- or pharmacist-led education (2 RCTs, OR 3.29 (1.91-5.66)) and for health risk 
appraisals (1 RCT, OR 2.17 (1.70-2.77)) for increasing influenza vaccination rates.  
Tuckerman et al. (2009 (++)) found three studies of educational interventions. One found that health 
education about Hepatitis B for homeless young people was effective (1 BA), one that education 
combined with reminders for rural families was not effective for DTP, polio, Hib, MMR and Hepatitis 
B vaccination  (1 cohort), and one that parent education about MMR was effective (1 nRCT).  
Williams et al. (2011 (++)), focusing on parents of young children, found two studies of parental 
education (1 RCT, 1 nRCT), one of which focused on low-SES parents. Both studies found the 
intervention to be ineffective in increasing vaccination rates (one for MMR, one for childhood 
vaccinations in general).  
Overall, the evidence on educational approaches is mixed, although this category encompasses a 




community media campaigns to be effective, but more mixed results for brochures and posters in 
clinical settings. One review (Thomas et al., 2010b (++)) shows nurse- or pharmacist-led education to 
be effective for older people. One review (Williams et al., 2011 (++)) shows parental education to be 
ineffective. There is limited information on the populations covered, so it is unclear how applicable 
these findings may be to TB. 
Evidence statement 2: Patient education to increase uptake of vaccinations 
There is mixed evidence from five reviews (Lau et al., 2012 (++); Moxey et al., 2003 (–); Ndiaye et al., 
2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++)) on the effectiveness of patient 
education interventions (other than reminders) in promoting the uptake of vaccination. One review 
(Lau et al., 2012 (++)) finds community media campaigns to be effective, with medium to large effect 
size. The findings on health education for patients or parents of young children are mixed. 
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. This may limit the applicability of the findings, due to cultural or 
other differences. 
4.5.3 Incentives or disincentives for patients 
Five reviews investigate some form of financial incentives or penalties (Lagarde et al., 2009 (+); Lau 
et al., 2012 (++); Ndiaye et al., 2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++)).  
Lagarde et al. (2009 (+)) found one study of conditional cash transfers in Mexico, showing them to be 
effective in increasing childhood vaccinations for TB and measles at 6 months but not at 12 months. 
Lau et al. (2012 (++)) found incentives to be effective for increasing influenza vaccinations among 
community-dwelling adults, i.e. those not resident in long-term care (5 comparisons, OR 1.98 (1.54-
2.56)). The incentives consisted of the provision of free vaccination (two studies), vouchers for 
preventive care services (one study), and cash incentives or lottery prizes (two studies). 
Ndiaye et al. (2005 (++)) found one study focusing on monetary incentives to increase hepatitis B 
vaccination among injecting drug users, which found the intervention to be effective (1 RCT, OR 8.43 
(3.95–18.0)) 
Thomas et al. (2010b (++)) found positive results from two studies evaluating the provision of free 
influenza vaccines to people aged 60 or over (2 RCTs, OR 2.36 (1.98-2.82) compared to invitations 
alone and OR 5.43 (2.85-10.35) compared to no intervention). 
Tuckerman et al. (2009 (++)) found two studies focusing on the use of penalties relating to welfare 
payments to increase uptake of vaccinations among low-income families in the USA (1 RCT, 1 CCT): 
one of these found significant improvements, while the other found no effect (one on DTP, OPV, Hib, 
MMR, and Hep B, one on DTP, OPV, and MMR). 
There is a limited evidence base overall on incentives and disincentives. Two reviews (Lau et al., 
2012 (++); Ndiaye et al., 2005 (++)) show incentives to be effective, but on the basis of relatively few 




inconclusive. There is some evidence that providing free vaccines is effective (Lau et al., 2012 (++); 
Thomas et al., 2010b (++)); however, this finding is of limited applicability to the UK context. 
Evidence statement 3: Incentives or disincentives for patients to increase uptake of vaccinations 
There is mixed evidence from five reviews on the effectiveness of incentives or disincentives for 
promoting the uptake of vaccinations (Lagarde et al., 2009 (+); Lau et al., 2012 (++); Ndiaye et al., 
2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++)). There is some evidence from two 
reviews that providing free vaccines is effective (Lau et al., 2012 (++); Thomas et al., 2010b (++)). 
There is some evidence from two reviews (Lau et al., 2012 (++); Ndiaye et al., 2005 (++)) suggesting 
that cash incentives may be effective. The evidence on conditional cash transfers (Lagarde et al., 
2009 (+)) and penalties for welfare recipients (Tuckerman et al., 2009 (++)) is inconclusive. 
Applicability 
There are potential limits to the applicability of this evidence: for example the provision of free 
vaccines is of limited relevance to the UK context; the evidence on conditional cash transfers is from 
Mexico, a middle-income country; and the evidence on welfare penalties is from the USA, and may 
represent a different policy context. 
4.5.4 Home visiting and lay health workers 
Seven reviews evaluate interventions using home visitors or lay health workers (LHWs) to engage 
with patients (Glenton et al., 2011 (++); Kaufman et al., 2013 (++); Lewin et al., 2010 (+); Selph et al., 
2013 (+); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++); Turnbull and Osborn, 2012 (++)). 
Overall these reviews suggest that these interventions are effective in increasing the uptake of 
vaccination. However, the underlying primary evidence base appears to be fairly small, and there is 
considerable duplication of primary studies between the reviews; this should be borne in mind in 
interpreting the findings.  
Glenton et al. (2011 (++)) found that LHW interventions targeted at disadvantaged families were 
effective in improving the number of children under 2 years whose vaccinations were up-to-date (4 
RCTs, RR 1.19 (1.09-1.30); four further studies presented limited data). 
Kaufman et al. (2013 (++)) found one RCT of a home visiting intervention for mothers of young 
children who used illegal drugs, which showed a non-significant adverse effect on vaccination rates 
for DPT, OPV, Hib and Hepatitis B (1 RCT, RR 0.67 (0.33-1.35)).2 
Lewin et al. (2010 (+)) investigated LHW interventions for disadvantaged families (one study looked 
at older people, and the others at parents of children under 5 years). The main component of these 
interventions consisted of home visits by trained peer health workers, with some also including 
other modes of communication. They found that these interventions were effective in increasing the 
number of people with vaccinations up-to-date (6 RCTs, RR 1.23 (1.09-1.38); one study was excluded 
from the meta-analysis as it reported insufficient data).  
                                                          
2
 This review included two other studies which measured relevant outcomes, but the reviewers did not extract 




Selph et al. (2013 (++)) evaluated a range of interventions to prevent child abuse and neglect. This 
review is included under this category as home visiting was a substantial component of many of the 
interventions, but some also included a screening component and/or elements of social work or case 
management. The findings of this review are mixed, with two of five comparisons (four studies) 
showing significant positive effects on vaccination-related outcomes, and three no significant effect. 
The types of vaccinations included in the study were not reported.  
Thomas et al. (2010b (++)), focusing on older people, found that home visits were more effective 
than invitation to attend the vaccination clinic for influenza immunisation alone (2 RCTs, OR 1.30 
(1.05-1.61)), and that home visiting with a care plan was effective compared to no intervention (1 
RCT, OR 8.15 (3.28-20.29)). However, home visits focused on promoting influenza vaccination were 
no more effective than home visits focusing on safety (1 RCT, OR 0.98 (0.64-1.50)). 
Tuckerman et al. (2009 (++)) found that home visiting interventions were effective in increasing 
childhood vaccination rates (5 RCTs, 1 BA) in a range of populations, including children not up-to-
date with vaccinations (DTP/OPV/Hib, MMR), low-SES families (one on DTP, OPV, Hib, MMR; one on 
DTP [DT], OPV or IPV, Hib, Hep B) , black and minority ethnic families (vaccines not reported), and 
children of teenage mothers (DTP, polio). They also found interventions which combine home 
visiting with reminder/recall interventions to be effective for low-SES families (1 RCT, 1 BA; one on 
DTP, OPV, Hib, Hep B, one on DTP, OPV, Hib, MMR). However, they found home visiting to be 
ineffective for mothers who used illegal drugs (1 RCT; the types of vaccinations included in this study 
were not reported). 
Turnbull and Osborn (2012 (++)) focused on home visiting by midwives for mothers who used drugs 
or alcohol: their review showed these interventions to be ineffective in increasing the number of 
children up-to-date with vaccinations (2 RCTs, RR 1.09 (0.91-1.32)). The vaccination types were not 
reported.  
As noted above, the underlying evidence base for these reviews appears to be fairly small. 
Nonetheless, it provides reasonably consistent evidence that home visiting interventions are 
effective in increasing vaccination uptake among disadvantaged parents of young children, and 
possibly older people, although effect sizes are generally modest. However, for parents who use 
drugs or alcohol, and parents who are at risk for child abuse or neglect, the evidence suggests home 
visiting is ineffective.  
It should be noted that many of the interventions were intended to provide support about a range of 
issues, mainly to do with parenting, and did not focus primarily on vaccination. One analysis (Thomas 
et al., 2010b (++)) suggests that the whether the intervention specifically targets vaccination or not 
may make little difference to its effectiveness. 
This category is of particular interest as most studies focus on disadvantaged populations, and may 
thus be more relevant to TB than many of the other categories.  
Evidence statement 4: Home visiting and lay health worker interventions to increase uptake of 
vaccinations 
There is strong evidence from four reviews (Glenton et al., 2011 (++); Lewin et al., 2010 (+); Thomas 




interventions are effective in increasing the uptake of vaccination. Home visiting has been found to 
be effective for socio-economically disadvantaged parents (Glenton et al., 2011 (++); Lewin et al., 
2010 (+); Tuckerman et al., 2009 (++)) and for older people (Thomas et al., 2010b (++)), although 
effect sizes are small. However, there is evidence from three reviews that home visiting 
interventions are ineffective for parents who use drugs or alcohol (Kaufman et al., 2013 (++); 
Tuckerman et al., 2009 (++); Turnbull and Osborn, 2012 (++)), and mixed evidence from one review 
for parents at risk for child abuse or neglect (Selph et al., 2013 (+)).  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with few or no studies 
from the UK. There may be limits to the applicability of this evidence resulting from the different 
cultural, policy or demographic contexts. 
4.5.5 Community engagement 
Two reviews investigated approaches they describe as ‘community-based outreach’ (Tuckerman et 
al., 2009 (++)) or ‘community engagement’ (Lau et al., 2012 (++)). Overall, the reviews suggest that 
these interventions are effective in increasing vaccination uptake. However, due to the nature of 
these interventions, there is considerable heterogeneity in intervention content in this category.  
Lau et al (2012 (++)) located two studies of similar interventions targeting influenza vaccination, and 
found them to be effective (OR 3.00 (1.28-7.03)). 
Tuckerman et al. (2009 (++)) included ten studies covering a range of outreach programmes focused 
on parents of young children. Some interventions adopt a more case-management approach, while 
others are more focused on raising awareness at community level, but all include some component 
of actively seeking out parents in order to deliver information and support. A range of populations 
were included in the studies, with most focusing on low-income and ethnic minority families. They 
found that these interventions were broadly effective in increasing vaccination uptake (5 RCTs, 1 
nRCT, 4 BA; included vaccinations: DTP, polio, Hib, MMR, Hepatitis B, OPV), although one study 
which followed up participants seven years after the intervention found that the intervention effect 
was not sustained.  
These reviews provide some evidence that community engagement approaches are effective in 
increasing vaccination uptake. As with home visiting, the evidence in this category may be of greater 
relevance to TB with respect to population than other interventions considered in this review. 
Evidence statement 5: Community engagement to increase uptake of vaccinations 
There is strong evidence from two reviews (Lau et al., 2012 (++); Tuckerman et al., 2009 (++)) that 
community engagement interventions, including outreach to at-risk groups and information or case 
management, are effective in increasing the uptake of vaccinations. These interventions appear to 
be effective for the general adult population (Lau et al., 2012 (++)) and for disadvantaged parents 





The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence resulting 
from the different cultural, policy or demographic contexts. 
4.5.6 Health checks and well-child clinics 
One review evaluated the effectiveness of regular ‘health checks’ in which patients are examined by 
a clinician, who may also provide specific risk assessments and preventative health advice and 
referrals (Boulware et al., 2006 (++)). This review found mixed results: of three RCTs, two showed 
significant positive effects and one a significant negative effect on influenza vaccination uptake; one 
retrospective comparative study showed mixed results for tetanus vaccination, and two non-
comparative studies showed positive effects. The studies in this review cover the general adult 
population, with most including Medicare and Veterans Administration service recipients in the USA. 
A broadly similar intervention evaluated in one review (Coker et al., 2013(+)) is ‘well-child clinics’, i.e. 
specialist preventive health services for parents of young children, incorporating clinical assessment 
and advice on child health, and in some cases also an educational component. This review found 
broadly positive results, with three studies (2 RCT, 1 nRCT) all finding significant positive impacts for 
well-child clinics on routine vaccination uptake. 
Evidence statement 6: Health checks and well-child clinics to increase uptake of vaccinations 
There is mixed evidence from one review (Boulware et al., 2006 (++)) on the effectiveness of routine 
health checks in increasing vaccination uptake. There is medium evidence from one review (Coker et 
al., 2013 (+)) that well-child clinics, i.e. specialist preventive services for parents of young children, 
are effective in increasing vaccination uptake. 
Applicability 
There is limited information on the country and context of the studies included in this category, and 
most appear to be in the USA. There may be limits to the applicability of this evidence to the UK 
resulting from the different contexts of health service delivery. 
4.5.7 School-based interventions 
One review investigated the impact of policies which require children to be vaccinated in order to 
attend school or day care (Tuckerman et al., 2009 (++)). This review found that such policies have 
generally positive impacts on vaccination uptake (2 BA, 2 cohort). Such policies focus on universally 
provided childhood vaccinations (Hepatitis B, DTP, polio, Hib, MMR, varicella), and hence may be of 
limited applicability to TB. 
The same review (Tuckerman et al., 2009 (++)) also looked at school-based education, finding 
evidence from one study that a multi-component education programme, including posters, reminder 
stickers, parent homework assignments and information brochures, is not more effective than 
standard printed information alone in increasing hepatitis B vaccinations (1 RCT). 




There is medium evidence from one review (Tuckerman et al., 2009 (++)) that policies requiring 
children to be vaccinated in order to attend school or day care is effective in increasing the uptake of 
childhood vaccinations. There is insufficient evidence on other school-based interventions. 
Applicability 
The majority of the evidence in this review appears to come from the USA, with no evidence from 
the UK. There may be limits to the applicability of this evidence to the UK resulting from the 
different contexts in terms of educational policy. 
4.5.8 National vaccination programmes 
One review (Tuckerman et al., 2009 (++)) considered the evidence on national vaccination 
promotion programmes, including policy changes, promotion campaigns, education for the public 
and service providers, and a range of other components. They found nine studies of two national 
campaigns (9 BA) which consistently indicated that such campaigns are associated with increases in 
vaccination uptake. Some analysis indicates that such interventions may reduce inequalities in 
vaccination coverage. One campaign focused on the MMR vaccine, the other on childhood 
vaccination in general. 
The evidence on national programmes is methodologically limited (it is challenging to evaluate such 
programmes using comparative designs), but promising. However, the evidence concerns childhood 
vaccinations for the general population. 
Evidence statement 8: national vaccination programmes to increase uptake of vaccinations 
There is medium evidence from one review (Tuckerman et al., 2009 (++)) that national vaccination 
programmes, including policy changes and promotion and education campaigns, increase the uptake 
of childhood vaccinations. 
Applicability 
The evidence in this review comes from Australia and Finland, with no evidence from the UK. There 
may be limits to the applicability of this evidence due to the different cultural or policy contexts. 
4.6 Provider-focused interventions 
4.6.1 Reminders to clinicians 
Eight reviews focused on the effectiveness of reminders delivered to clinical staff to increase the 
uptake of vaccinations (Arditi et al., 2012 (+); Holt et al., 2012 (++); Lau et al., 2012 (++); Ndiaye et 
al., 2005 (++); Shojania et al., 2011 (++); Souza et al., 2011 (++); Thomas et al., 2010b (++); 
Tuckerman et al., 2009 (++)). Such reminders are generally integrated into computer systems in 
clinical practices, and may be delivered to clinicians electronically or in printed formats. Overall, the 
reviews generally show clinician reminders to be effective, although there are some more mixed 
findings. 
Arditi et al. (2012 (+)) investigated the effectiveness of computer-generated reminders delivered on 
paper to healthcare professionals. They found these interventions to be effective in increasing 




improvement 13.1% (interquartile range 12.2% to 20.7%)). Some of the interventions included in this 
review also included other components, such as clinician education or audit and feedback. 
Holt et al. (2012 (++)) found that clinician reminders, generated by patient-specific information and 
provided either on screen or on paper, were effective at increasing influenza and tetanus 
immunisation rates (2 RCTs, OR 4.69 (1.25-17.53)).  
Lau et al. (2012 (++)), focussing on older people, found clinician reminders to be effective in 
increasing influenza vaccination rates (30 comparisons, OR 1.53 (1.26-18.5)) and pneumococcal 
vaccination rates (27 comparisons, OR 2.13 (1.50-3.03)).  
Ndiaye et al. (2005 (++)) found seven studies showing provider reminder system to be effective in 
increasing influenza or pneumococcal vaccination rates (4 RCTs, 2 retrospective cohorts, 1 ITS, 
median change +17.9%). The reminder types varied and included notations in clients’ charts, chart 
prompts or stickers, and checklists generated by the clinical staff computer databases.  
 
Shojania et al. (2011 (++)) identified six studies (4 RCTs, 2 nRCTs) that examined the effectiveness of 
computer reminders for physicians regarding eligibility for vaccinations or guidelines to manage 
chronic diseases. This review concluded that such reminders were effective at improving the 
prescription of recommended vaccinations, although effect sizes were relatively limited (median 
3.8% (IQR 0.5% to 6.6%) on the median outcome from each study, 4.8% (IQR 0.5% to 7.8%) on the 
best outcome). The authors did not specify the vaccine types included in these studies.   
Souza et al. (2011 (++)) reported mixed effectiveness for interventions that utilised computer 
systems to deliver reminders to offer vaccination for influenza, pneumococcal disease or tetanus (13 
RCTs). Six studies report significant positive impacts on vaccination rates (and one further study 
reports positive results whose significance is unclear), five studies no significant effect, and one 
mixed results.  
Thomas et al. (2010b (++)) examined clinician reminders aimed at increasing influenza vaccination 
rates amongst adults over the age of 60. Four RCTs focussed on reminders provided directly to 
physicians and found mixed evidence for effectiveness: one study found a significant positive effect, 
two studies showed no effect and one study showed a significant negative effect.  
Tuckerman et al. (2009 (++)) found two studies showing reminder systems to be effective at 
increasing the proportion of infants receiving timely vaccinations (1 ITS, 1 BA; one for BCG, one for 
DTP and OPV).  
Overall, several reviews show that clinician reminders to increase vaccination uptake are effective, 
although some reviews have more mixed findings, and the reasons for the difference are not 
obvious. The reviews thus provide indicative but not conclusive evidence of effectiveness. There is 
limited information available on the study populations or practice contexts, which may limit 
applicability. 
Evidence statement 9: Reminders to clinicians to increase uptake of vaccinations 
There is strong evidence from six reviews (Arditi et al., 2012 (+); Holt et al., 2012 (++); Lau et al., 




reminders to clinicians are effective in increasing vaccination uptake. However, two reviews report 
more mixed findings (Souza et al., 2011 (++); Thomas et al., 2010b (++)). Two meta-analytic reviews 
(Holt et al., 2012 (++); Lau et al., 2012 (++)) show medium to large effect sizes.  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence due to the 
different contexts of health service delivery. 
4.6.2 Incentives and bonus payments for providers 
Six reviews included studies of various forms of incentive or bonus payment to service providers, 
including pay-for-performance schemes or straightforward per-vaccination payments (Eijkenaar et 
al., 2013 (–); Houle et al., 2012 (+); Lau et al., 2012 (++); Scott et al., 2011 (+); Thomas et al., 2010b 
(++); Tuckerman et al., 2009 (++)).  
Eijkenaar et al. (2013 (–)), a review of 8 systematic reviews, examined small increases in clinicians’ 
payment for reaching vaccination targets and found that such interventions were broadly effective 
in increasing vaccination rates (effect range +4% to +7%). However, this review of reviews is not well 
reported and there is limited detail on the interventions or findings. 
Houle et al. (2012 (+)) identified 8 studies (2 RCTs, 1 nRCT, 1 cohort, 4 BA) focussing on bonus 
systems to encourage clinician adherence to vaccination guidelines. This review broadly found such 
systems to be effective in increasing vaccination rates. Two RCTs examining payment-for-
performance (P4P) compared to fee-for-service found small but significant improvements in 
vaccination rates. One nRCT also found P4P to be effective for influenza vaccination uptake. Four BA 
studies found P4P to be effective in increasing MMR (2 BA) and influenza vaccination rates (2 BA). A 
final cohort study, however, found that P4P did not have a significant effect on influenza vaccination 
rates. 
Lau et al. (2012 (++)) found financial incentives for clinicians aimed at improving vaccination uptake 
rates amongst older people were effective for influenza vaccinations (3 comparisons, OR 1.52 (1.20-
1.93)) and pneumococcal vaccinations (1 comparison, OR 7.43 (2.25-24.53)). 
Scott et al. (2011 (+)) found one controlled before-after study that examined the impact of changing 
the way that NHS general practitioners were paid, switching from capitation to salaried contracts, 
which found a slight adverse effect in childhood vaccination rates (significance not reported). They 
identified one further study using a controlled interrupted time series design that evaluated the 
impact of bonuses paid to medical groups in California. The study review authors report a 
statistically significant difference in the change in the childhood immunisation rate, which was due 
to a large fall in the rates of the control group.  
 
Thomas et al. (2010b (++)) found financial incentives offered to physicians for improving influenza 





Tuckerman et al. (2009 (++)) found 8 BA studies that examined a large Australian programme that 
included provider incentives for immunisation (cf. also section 0 above). The studies found that the 
campaign resulted in an increase in age-appropriate vaccination coverage.  
The evidence base on clinician incentives appears not to be very extensive, and there is some 
duplication of primary studies in the reviews presented here, particularly between Lau et al. (2012 
(++)) and Thomas et al. (2010b (++)). There is some promising evidence that incentive or pay-for-
performance schemes may have a positive impact on vaccination rates, although the evidence is not 
entirely consistent. Much of the evidence is from countries other than the UK, and there may be 
limits to its applicability to the UK context, given major differences in the organisation and financing 
of healthcare services. 
Evidence statement 10: Incentives and bonus payments to providers to increase uptake of 
vaccinations 
There is medium evidence from six reviews (Eijkenaar et al., 2013 (–); Houle et al., 2012 (+); Lau et 
al., 2012 (++); Scott et al., 2011 (+); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++)) that 
incentives and bonus payments to clinicians or practices, such as pay-for-performance schemes or 
payments per vaccination carried out, is likely to increase vaccination uptake. Two meta-analytic 
reviews (Lau et al., 2012 (++); Thomas et al., 2010b (++)) find medium to large effect sizes.  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence to the UK 
resulting from the different policy contexts and healthcare funding systems. 
4.6.3 Clinician education 
Five reviews looked at various forms of education programmes for service providers to increase 
vaccination uptake among their patients (Lau et al., 2012 (++); Ndiaye et al., 2005 (++); Thomas et 
al., 2010b (++); Tuckerman et al., 2009 (++); Williams et al., 2011 (++)). The findings of the reviews 
are mixed overall. 
Lau et al. (2012 (++)) found clinician education programmes to be effective for increasing the uptake 
of pneumococcal vaccination (7 comparisons, OR 1.54 (1.19-1.99)) but not influenza vaccination (8 
comparisons, 0.99 (0.94-1.04)).  
Ndiaye et al. (2005 (++)) found one study of clinician education which showed no significant effect 
on influenza vaccination rates (1 nRCT). 
Thomas et al. (2010b (++)) investigated interventions which involve facilitators visiting practices on a 
regular basis, and working directly with clinicians and healthcare teams to promote influenza 
vaccination among older people. Of four RCTs, three show a significant positive effect for such 
interventions and one no significant effect.  
Tuckerman et al. (2009 (++)) found four studies of programmes to educate clinicians (all four focus 
on BCG vaccination for TB, and all but one are included in the main lot 1 review). All these studies 




infants. However, interventions to provide clinicians with information about children’s vaccination 
status were ineffective in increasing vaccination uptake (1 RCT, 1 BA).  
Williams et al. (2011 (++)) found four studies of clinician education to improve vaccination rates in 
children (1 RCT, 1 nRCT, 2 BA). Two studies looked specifically at disadvantaged populations. Only 
one (non-comparative) study showed a significant positive effect; the other three showed a positive 
but non-significant direction of effect. Vaccination type was only specified for one study and 
included DTP, OPV and MMR vaccinations.  
Overall the evidence for clinician education appears to be limited in extent, and the results are 
mixed. The findings of the studies included in Tuckerman et al. (2009 (++)) are considered in more 
depth in the main lot 1 review. The other reviews show mixed and inconclusive findings. One review 
(Thomas et al., 2010b (++)) suggests that facilitators working with clinicians may be effective. 
Evidence statement 11: Clinician education to increase uptake of vaccinations 
There is mixed evidence from five reviews (Lau et al., 2012 (++); Ndiaye et al., 2005 (++); Thomas et 
al., 2010b (++); Tuckerman et al., 2009 (++); Williams et al., 2011 (++)) regarding clinician education 
programmes to promote vaccination. Two reviews indicate that clinician education does not have a 
significant effect (Ndiaye et al., 2005 (++); Williams et al., 2011 (++)), one indicates that it is effective 
(Tuckerman et al., 2009 (++)), and one shows mixed findings (Lau et al., 2012 (++)). One review 
(Thomas et al., 2010b (++)) indicates that facilitators working with clinical practices may be effective 
in increasing vaccination uptake. 
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There are no obvious limits to the applicability of this evidence. 
4.6.4 Audit and feedback 
Five reviews evaluated interventions involving the audit of clinical services, with some form of 
feedback to healthcare staff of results on their performance as individuals or teams, as a means to 
improve service provision and hence the uptake of vaccination (Lau et al., 2012 (++); Ndiaye et al., 
2005 (++); Thomas et al., 2010b (++); Tuckerman et al., 2009 (++); Williams et al., 2011 (++)). Such 
interventions may be undertaken alone or with broader interventions using a social influence model 
(e.g. clinician peer education). Overall, the findings from the reviews are mixed. 
Lau et al. (2012 (++)) found audit and feedback interventions to be effective for influenza vaccination 
(4 comparisons, OR 1.83 (1.28-2.61)), but not for pneumococcal vaccination (3 comparisons, OR 1.18 
(0.57-2.45)). They also found that continuous quality improvement approaches are not effective (4 
comparisons, OR 0.99 (0.94-1.04) for influenza and OR 1.86 (0.66-5.21) for pneumococcal). 
Ndiaye et al. (2005 (++)) found one study of an audit and feedback intervention in a hospital setting, 
which showed it to be effective in increasing influenza and pneumococcal vaccination (1 BA).  
Tuckerman et al. (2009 (++)) found one study of an intervention incorporating feedback with peer 
influence, which showed it to be effective in increasing DTP, OPV and MMR vaccination uptake 




and opportunistic vaccination policies, which showed it to be effective in increasing DTP and Hib 
vaccination uptake among children in a deprived area (1 BA). Finally, they also find that process 
improvement approaches at practice level are effective in increasing vaccination rates among low-
income families (1 RCT); this intervention involved reviewing data to identify suboptimal delivery of 
preventive services, and then implementing and monitoring evidence-based changes to improve 
delivery of services (e.g. flow sheets), with on-going support from the project team. 
Thomas et al. (2010b (++)) compared different forms of feedback intervention to increase influenza 
vaccination rates. They found:  
 no significant effect for a programme of academic detailing (i.e. educational visits by 
clinical academics, not further described) and peer comparisons compared to mailed 
educational materials alone (1 RCT, OR 1.13 (0.80- 1.58));  
 a significant effect for review and feedback with benchmarking, compared to review and 
feedback alone (1 RCT, OR 3.43 (2.37-4.97);  
 a significant negative effect for educational outreach and feedback compared to 
feedback alone (1 RCT, OR 0.77 (0.72-0.81)).  
Williams et al. (2011 (++)) found four studies of clinician feedback interventions evaluating childhood 
vaccination outcomes (2 RCT, 1nRCT, 1 BA). Two studies looked specifically at low-SES children. Two 
studies find a significant positive effect of a feedback intervention (1 study vaccination type not 
reported; 1 study DTP, OPV and MMR); one finds feedback in conjunction with clinician bonuses to 
be effective for DTP, Hib, OPV and MMR vaccination, but not feedback alone; and the fourth finds no 
significant difference between feedback with peer education and feedback alone (vaccination type 
not specified). 
 
Evidence statement 12: Audit and feedback to increase uptake of vaccinations 
There is mixed evidence from five reviews (Lau et al., 2012 (++); Ndiaye et al., 2005 (++); Thomas et 
al., 2010b (++); Tuckerman et al., 2009 (++); Williams et al., 2011 (++)) regarding the effectiveness of 
clinical audit and feedback interventions on the uptake of vaccination. Two reviews suggest that 
these interventions are effective (Ndiaye et al., 2005 (++); Tuckerman et al., 2009 (++)), while the 
findings of the other three are mixed (Lau et al., 2012 (++); Thomas et al., 2010b (++); Williams et al., 
2011 (++)).  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence resulting 
from the different contexts of clinical practice. 
4.6.5 Changes to service delivery 
Three reviews also covered a range of provider-oriented interventions which involve the 
reorganisation of services, or delivering vaccination services in different ways (Lau et al., 2012 (++); 
Ndiaye et al., 2005 (++); Tuckerman et al., 2009 (++)). The results suggest that several such changes 




Lau et al. (2012 (++)) found the following. Group visits for people with chronic diseases are effective 
(2 comparisons, OR 2.44 (1.42-4.20) for influenza and OR 2.25 (1.30-3.92) for pneumococcal). 
Delivering vaccination services in alternative sites, such as patients’ homes or worksites or 
community pharmacies, is effective (7 comparisons, OR 1.32 (1.14-1.52) for influenza and OR 1.66 
(1.59-1.74) for pneumococcal). Changes to the team involved in delivering services, such as training 
nurses to give vaccinations, is effective (34 comparisons, OR 1.44 (1.16-1.79) for influenza and OR 
2.09 (1.48-2.95) for pneumococcal). Findings on case management approaches were mixed (7 
comparisons, OR 1.66 (0.81-3.43) for influenza and OR 1.49 (1.05-2.13) for pneumococcal).  
Ndiaye et al. (2005 (++)) evaluated interventions which combine patient education or reminders with 
changes to services to increase accessibility, such as extended opening hours or special vaccination 
clinics, for influenza, hepatitis B and pneumoccal vaccination. They find six studies, all of which 
indicate some positive effect, four significantly (6 RCTs).  They also find two studies of changes in 
hospital vaccination policy, one of which shows a significant effect and the other no effect (1 RCT, 1 
nRCT).  
Tuckerman et al. (2009 (++)) investigated several service-level or provider-oriented interventions. 
They find evidence that ‘opportunistic’ vaccination policies are effective in increasing vaccination 
rates among patients attending hospital (1 RCT, 1 cohort, 5 BA), but more mixed results for such 
policies in the context of GP services (1 RCT, 2 nRCTs). They find that offering hepatitis B vaccination 
to injecting drug users in prisons is effective in increasing uptake (1 BA). Changes to hospital policy 
around hepatitis B vaccination may be effective, with three of four studies showing some positive 
change (2 cohort, 2 BA).  
This category subsumes a wide range of interventions. Nonetheless, there is promising evidence for 
the effectiveness of several interventions. In particular, one review (Lau et al., 2012 (++)) shows that 
changing the site where vaccinations are offered (e.g. worksites or homes), or the personnel carrying 
out vaccinations (e.g. nurses rather than doctors), can be effective in increasing uptake. Ndiaye et al. 
(2005 (++)) suggests that changes to services to increase accessibility are effective. The findings of 
Tuckerman et al. (2009 (++)) regarding changes to vaccination policy in hospitals and prisons are also 
promising. These findings suggest that a range of changes to service delivery models may be 
effective in increasing uptake of vaccination, although some findings may be of limited applicability 
to TB. 
Evidence statement 13: Changes to service delivery models to increase uptake of vaccinations 
There is strong evidence from three reviews (Lau et al., 2012 (++); Ndiaye et al., 2005 (++); 
Tuckerman et al., 2009 (++)) that a range of changes to service delivery are effective in increasing 
vaccination uptake. One review (Lau et al., 2012 (++)) shows that delivering vaccination services in 
alternative sites (such as patients’ homes or worksites or community pharmacies), and changing the 
team involved in delivering services (e.g. training nurses to give vaccinations) are both effective, with 
medium to large effect sizes. One review shows that group visits for people with chronic diseases are 
effective (Lau et al., 2012 (++)). One review finds mixed evidence for case management (Lau et al., 
2012 (++)). One review shows that increasing clinic accessibility (e.g. extended opening hours) in 
conjunction with education or reminders is effective (Ndiaye et al., 2005 (++)). One review finds that 




(Tuckerman et al., 2009 (++)). The findings on hospital vaccination policies are mixed (Ndiaye et al., 
2005 (++); Tuckerman et al., 2009 (++)).  
Applicability 
The majority of the evidence in these reviews appears to come from the USA, with only a small 
amount of evidence from the UK. There may be limits to the applicability of this evidence resulting 
from the different health system or demographic contexts. 
4.7 Programmes for healthcare workers 
Programmes focusing on increasing the uptake of vaccination among healthcare workers (HCWs) are 
considered here as a separate category, as they have some elements of both provider- and patient-
focused approaches. Five reviews investigated such approaches (Burls et al., 2006 (+); Jordan et al., 
2004 (+); Lam et al., 2010 (++); Ndiaye et al., 2005 (++); Thomas et al., 2010a (+)), and all included a 
similar range of interventions, generally multi-component programmes incorporating a combination 
of information and vaccination promotion activities with some changes to services (e.g. on-site 
vaccination clinics) in order to increase vaccination among HCWs. The reviews cover a range of 
healthcare settings, including hospitals, primary care and long-stay care for older people. All the 
reviews but one (Ndiaye et al., 2005 (++)) focus exclusively on influenza vaccination. 
Burls et al. (2006 (+)) found mixed results: of three studies using designs with a control group, one 
shows no effect and one a significant positive effect (one shows a positive effect but does not report 
significance), while of four studies with no control group, all show positive effects but significance is 
only reported for one. 
Jordan et al. (2004 (+)) found a significant positive effect from one nRCT, and positive effects but 
with significance not reported in two RCTs and four non-comparative studies. 
Lam et al. (2010 (++)) found that in non-hospital settings (mainly long-term care), eight of nine 
comparisons showed a positive effect (4 RCTs, 1 BA). In hospital settings the findings were more 
mixed, with six of 14 comparisons showing a significant positive effect, one a significant adverse 
effect, and seven no significant effect (in six of these the direction of effect was positive). Subgroup 
analyses suggested that while interventions involving educational or promotional approaches alone 
tend not to be effective, multi-component interventions, such as those involving both an educational 
component and improvements to the accessibility of vaccination services, are more promising. 
Ndiaye et al. (2005 (++)) found positive effects in four studies of long-term care and primary care, 
although significance is reported only in one (2 nRCT, 2 BA). Three of these studies focused on 
influenza vaccination, and one on hepatitis B. 
Thomas et al. (2010a (+)) focused on HCWs who work with older people, and found two studies, 
both of which find positive effects, although significance is not reported in the review (2 RCTs).  
The findings on programmes for healthcare workers are thus mixed overall. According to the review 
reports, there are considerable limitations in the design and reporting of the primary studies. 
Direction of effect in the primary studies appears to be mostly positive, but often does not reach 




(++)) indicates that multi-component approaches combining education or promotion with increased 
accessibility of services are more likely to be effective than promotion of vaccination alone. 
Almost all the available data on HCW interventions focus on influenza vaccination, and there is 
limited information on the populations of HCWs and settings included. This may limit the 
generalisability of the findings to HCWs who work with TB patients (for whom BCG is 
recommended), although it is likely that the results may be considered generally relevant. 
Evidence statement 14: Programmes to increase uptake of vaccinations among healthcare workers 
There is mixed evidence from five reviews (Burls et al., 2006 (+); Jordan et al., 2004 (+); Lam et al., 
2010 (++); Ndiaye et al., 2005 (++); Thomas et al., 2010a (+)) regarding the effectiveness of multi-
component interventions, generally combining education and changes to vaccination service 
delivery, to increase the uptake of vaccination among healthcare workers. These reviews find that 
although most studies show some positive direction of effect, in most cases it does not attain 
significance.   
Applicability 
The evidence in these reviews appears to come from a range of countries, with relatively little 
evidence from the UK. There may be limits to the applicability of this evidence resulting from 






5.1 Overview of findings 
This review of systematic reviews covers a wide range of strategies which have been evaluated for 
promoting the uptake of vaccinations. The intervention category with the strongest evidence overall 
is reminder and recall interventions, for which there appears to be substantial evidence of positive 
effects. Several other intervention categories show promising but not absolutely conclusive results, 
including: provider reminders; provider incentives; home visiting; national vaccination programmes; 
community engagement; improvements to the accessibility of services; changes to the staffing of 
services; and offering services in different locations, such as community sites. 
The evidence for many types of intervention is more mixed, and the reviews do not provide strong 
evidence of effectiveness. These include: patient education; patient incentives and disincentives; 
provider education; and provider audit and feedback. Multi-component interventions to promote 
vaccination among healthcare workers also show somewhat mixed results. 
We might attempt to summarise over the findings as follows. Purely educational or informational 
approaches, either for patients or service providers, are not strongly supported by the evidence, 
although national- or community-level multi-component campaigns may be more promising. 
Systemic or policy-level changes in the provision of vaccination services are promising, including 
changes to the site or personnel involved in delivering services. Policies aiming to change the 
behaviour of clinicians offering general health services, including opportunistic vaccination policies 
and clinician reminders, are also promising. Approaches which involve more direct engagement with 
targeted individuals or communities, such as home visiting or community outreach, are also 
promising, although they may not be effective for some hard-to-reach groups. 
5.2 Strengths and limitations of the review 
This review of reviews was carried out systematically, with a priori inclusion criteria and data 
extraction to minimise bias in the review process. We included only reviews which reported their 
search strategies, inclusion criteria, and quality assessment processes, to provide a minimum 
baseline of methodological rigour at the level of the included reviews. We used a standardised tool 
to assess quality and extract data. 
The search was not fully comprehensive, and focused on databases specialising in health research. 
Hence, some reviews may not have been located. Searches were limited to reviews published in 
2003 or later. However, many of the primary studies in the included reviews are earlier than this, so 
the review provides an overview of research over a longer time frame. 
By their nature, reviews of reviews are at some distance from the evidence. We did not retrieve the 
included primary studies, and so could not engage in detailed assessment of their quality, or extract 
further data when information was not provided in the review reports. We also did not carry out any 
analysis of the extent to which primary studies overlap between reviews, and may have been 
double- or triple-counted in the synthesis, although this has been noted within the results where it is 
obvious. The reporting of the included reviews varied widely, with some providing exhaustive detail 
on intervention content, implementation, context and population, and others providing very 




categorise the interventions they investigate, which, combined with the lack of detail on 
intervention content, makes it difficult to draw detailed conclusions. 
As noted in the evidence statements, few of the studies included in the included reviews appear to 
have been conducted in the UK, with most evidence coming from the USA. This may limit the 
applicability of some findings to the UK context. This is particularly an issue for the provider-focused 
interventions, due to differences in the context of healthcare policy, funding and service delivery, 
and arguably for interventions targeting specific disadvantaged populations, due to differences in 
population demographics and culture. 
 
5.3 Applicability to TB/BCG 
Potential barriers to the applicability of the evidence to the context of BCG vaccination for TB have 
been noted throughout the results section. There are two main issues here: the types of vaccination 
considered, and the populations included in the reviews. 
Most evidence, other than that on healthcare workers, concerns either vaccinations offered 
universally either as part of the standard childhood vaccination schedule (e.g. DTP) and/or to older 
people (e.g. influenza). Vaccinations such as BCG which are recommended for particular selected 
populations may face different barriers to uptake, both at patient and provider level. Many of the 
interventions discussed above could probably be adapted to the context of selective vaccinations. 
Nonetheless, the evidence on their effectiveness presented in this review may not be applicable to 
the context of BCG, where interventions may face greater challenges in reaching and engaging their 
targeted populations.  
Because the focus of the great majority of the evidence is on vaccinations provided universally either 
to infants or young children, or to older people (e.g. influenza), studies tend to evaluate 
effectiveness with general-population samples. We have noted where the reviews considered 
disadvantaged populations specifically, but most of these results concern low-SES groups, rather 
than the more specific populations for whom BCG is recommended. Moreover, even this minimal 
information on populations is patchy for the patient-oriented interventions, and almost entirely 
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7 Appendix 1. Search strategies  
Literature searching was conducted Tuesday June 11th 2013. The full details of the searches as run 
are provided below. 
Searches were limited 2002-Current in line with the review protocol. The searches were not limited 
by population nor were they restricted by language. 
Database Hits 
Medline 1216 
Embase 2005  
Cochrane Library – CDSR, DARE and HTA 435 (see notes) 
PROSPERO 0 
Total 3656 
- de-duplication 1333 
Unique Records to Screen 2323 
 
Strategy Annex 
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R 
Host: OVID 
Data Parameters: 1946 to Present 





# Searches Results 
1 
(vaccin$ or revaccinat$ or immunisation or immunization or immunis$ or immuniz$ or 
inoculat$).ti,ab,kw. 
362776 
2 exp Immunization/ 133503 
3 *Immunization Programs/ 4721 
4 *Communicable Disease Control/ 11647 
5 1 or 2 or 3 or 4 418284 
6 (systematic$ adj5 review$).ti,ab,kw. 52833 
7 Meta-Analysis.pt. 42741 
8 meta analy$.ti,ab,kw. 55176 
9 metaanaly$.ti,ab,kw. 1294 
10 6 or 7 or 8 or 9 104126 
11 5 and 10 1388 










Data Parameters: 1980 to 2013 Week 23 




# Searches Results 
1 
(vaccin$ or revaccinat$ or immunisation or immunization or immunis$ or immuniz$ or 
inoculat$).ti,ab,kw. 
384841 
2 exp Immunization/ 195521 
3 *infection control/ 23530 
4 1 or 2 or 3 457869 
5 (systematic$ adj5 review$).ti,ab,kw. 62187 
6 exp "Systematic Review"/ 60954 
7 (meta-analys$ or meta analys$ or metaanalys$).ti,ab,kw. 68848 
8 5 or 6 or 7 133199 
9 4 and 8 2177 
10 limit 9 to yr="2002 -Current" 2005 
 
Notes: N/A 
File Name: EMBASE 
 
Database: The Cochrane Library – CDSR, DARE and HTA 
Host: The Cochrane Library via http://www.thecochranelibrary.com/view/0/index.html 
Data Parameters: Issue 2 of 4, Apr 2013 (for all) 
Date Searched: Tuesday, June 11th 2013 
Hits: CDSR: 145; DARE: 218; HTA: 143. (total: 506) 
Strategy: 
 
ID Search Hits 
#1 (vaccin* or revaccinat* or immunisation or immunization or immunis* or immuniz* or 
inoculat*):ti,ab,kw  (Word variations have been searched) 11701 
#2 MeSH descriptor: [Immunization] explode all trees 3798 
#3 MeSH descriptor: [Immunization Programs] this term only 305 
#4 MeSH descriptor: [Communicable Disease Control] this term only 94 





Notes: A filter to limit to reviews was not used. Instead, the contents of CDSR, DARE and HTA 
were exported – acting as a proxy methods filter.  For completeness of reporting, the other 
libraries returned hits as followed: CENTRAL: 10499; Methods: 149; NHS EEDS: 711. 
 
The date limiter did not work in the search. Accordingly, each library (CDSR, DARE and HTA) was 
downloaded separately and pre-2002 records were removed manually. N taken forward for 
screening became 
 
CDSR: 138; DARE 218; HTA 119. Making N=435   
 








(vaccin* or revaccinat* or immunisation or immunization or immunis* or immuniz* or inoculat*) 
 
Notes: N/A 
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Citation: Arditi, C., 
Rege-Walther, M., 














Reviews. 12, 1-99. 
 
Aim of the review: 





Register of Controlled 
Trials (CENTRAL), 
MEDLINE (and In-














lists of key articles and 
relevant reviews and 
contacted authors of 
relevant reviews and 
studies regarding any 






























(more information not 
provided); or physician 
reminders alongside 
educational meeting; 
audit and feedback 
 
Control/comparison/s
/ description:  
Most usual care; 1 
patient reminder, 
educational meeting, 






















Median improvement of 
13.1% (IQR 12.2% to 
20.7%) (p=0.02) (across 
9 studies) 
 




Providers: 20-135 (not 
always reported) 




author: Did not 
consider the 
effectiveness of 
reminders as part 






not be assessed. 
Using the median 
effect across 
studies as effect 
size limits the 
interpretation of 
the results 
(precision of study 














delivered on paper 
to healthcare 
professionals on 











Review design: SR 










including study type, 
country: 









on paper to 
healthcare 
professionals delivery 




processes of care 
(related to healthcare 
professionals’ 
practice), continuous 
processes of care, 
dichotomous 
outcomes of care 














40-60; ≥ 65 
years old or 














diabetics; > 18 


















outcome data for 




were included in 
the vaccination 
grouping for the 



















computer merely used 
as a medium to print 
the reminder without 










listing all the drugs a 
patient was currently 
taking (e.g. drug 
profile) or a document 
summarizing the 
medical records, with 
no rules applied in the 
computer, new clinical 
information collected 
directly from patients 
on a computer and 
given to the provider 




























outcomes of care 








the study; cluster 
randomization 




Number of studies 
included: 
32 studies (27 RCTs, 5 
nRCTs) 
 
Number of relevant 
studies included: 9 
 
be appropriate 
and should not be 
uncritically 
assumed always 
to be a solution as 





2007); if using a 
cluster design, use 
rigorous statistical 
methods and 
report all relevant 
data (Campbell 



























learning effect of 
reminders (after 



















































L.E.; Barned, G.F., 
Wilson, R.F., et al. 








Aim of the review: 
"1. What 
definitions are used 
for the adult PHE 
[periodic health 
evaluation] in 
studies of its value? 
2. What is the 
evidence that a 
PHE...is associated 
with benefits... 
compared to care 
without a PHE...? 3. 










Hand searching of 24 






2006; no limit by year 
 
Inclusion criteria, 
including study type, 
country: Studies 
comparing one group 
receiving a PHE to a 
group not receiving 




















mostly USA and 
patients in 













over 70; adult 
Intervention/s 
description: Periodic 
health evaluation (risk 
assessment and 
examination by a 
clinician, with provision 
of preventive services 
and/or advice, referrals 
etc); some studies 





























Outcomes: Of three 




(Cohen’s d (95% CI): 
0.10 (0.10, 0.10) and 
0.35 (0.33, 0.36)), and 
one a negative effect (-
0.22(-0.20,-0.24)); One 
retrospective cohort 
study shows a 
significant effect on 
uptake of tetanus 
vaccination (RR=1.72 
(1.1-2.7)) but not on 
influenza vaccination 
(RR=1.01 (0.8-1.3)); Two 
observational pre-post 
studies show a positive 
effect on uptake 
outcomes (details not 
reported). 
 
Results on inequalities: 
Not reported 
 
Sample sizes: 136-2558 
 
Attrition details: 4% 
Limitations 
identified by 




















up. Limited data 
on context of 
studies, and full 
quantitative 
outcome data are 






evidence that a 
PHE...is associated 
with harms...? 4. 
What system-based 
interventions 
improve the receipt 
or delivery of the 






Review design: SR 






"Not English language 
No human data 
Meeting abstract--no 
full article for review 
Includes ONLY 
subjects less than 18 
year of age Exposure 
is NOT the PHE (at 
least one group in the 
intervention must 
meet the minimum 
definition of the PHE) 
Article focuses on 
specific preventive 
measures ONLY 
without mention of 
the global PHE Clinical 
preventive services 
delivered only during 
opportunistic visit 
(e.g., illness or 
symptom-related 
visit) without mention 
of the PHE Article 
does not apply to any 
of the key questions 
No Original Data No 
eligible comparison 
group (not pre-post, 
historical control, 
clinical trial, or 
concurrent cohort)" 




score:  ̶  
 
 
and 33% for two of the 





s for future 
research: Studies 
of potential harms 










of costs. Studies 















both groups received 
a PHE 
 
Number of studies 
included: 36 
 
Number of relevant 
studies included: (3 
RCTs, 1 retrospective 




















Citation: Burls, A., 
Jordan, R., Barton 




to protect the 
vulnerable--is it a 




of the evidence 
















HEED, DARE, MEDLINE 
and EMBASE (to June 
2004), Internet sites 
[not specified], 






contact with experts 
 
Years searched: To 




including study type, 
country: Design: any;  
Population: HCWs in 
hospitals, nursing 
homes or the 

































































(N=3): one study 
(cluster RCT) shows no 
sig effect (primary 
healthcare 21.9% 
intervention, 21.0% 
control (p = 0.91); 
nursing homes 10.2% 
intervention, 5.6% 
control (p = 0.34) 
[presumably post-test 
only]). One study 
(cluster RCT) shows a sig 
improvement in uptake 
(OR 2.8 (1.4–5.8)). One 
study (before-after with 
control arm) shows 
'45% increase', sig NR. 
Non-comparative 
studies (N=4): all (4 
before-after 
studies)show increase in 
uptake (range 14%-41% 
absolute increase), but 
only one sig eff (others 
sig NR) 
 














limitations of the 
underlying 
evidence; best-
quality study finds 
no sig effect of 
intervention. 
Focus of review is 


















Review design: SR 
of effectiveness, 
cost-effectiveness 






or vaccine unrelated 
to influenza; Primary 
outcomes (in high-risk 















uptake; methods of 
attaining uptake; 
absenteeism. 
Exclusion criteria: Not 
reported 
 
Number of studies 
included: 18 
 
Number of relevant 







Sample sizes: 268-2984 
for trials; 195-5514 for 
non-comparative 
studies 
Attrition details: Not 
reported 
research: More 
















cRCTs,1 BA with 




















Citation: Coker, T. 
R., Windon, A., 









131 (S1), S5-S25.  
 
Aim of the review: 
"to examine tools 




for US children 
aged 0 to 5, 
focusing on 
changes to the 













February 1 2012 
 
Inclusion criteria, 






Study topic: WCC 
clinical practice 
redesign; Target 
population aged 0–5 
years; Country: 
developed nation; 
Peer reviewed and 










4-15 months at 






















description: Group well 
children care (GWWC): 
families are seen for a 
well-child visit in a 
group of 4 to 6 families 
with similarly aged 
children for 60-90 





immunization of each 
child; Physician/nurse 
practitioner (NP) 
alternating WCC visits; 
Social worker at 2-wk 
visit; Waiting-room 
health education by NP 
and trained volunteers 
using video and slides; 
HS (Healthy Steps for 
Young Children 
Program, program in 
which a physician and 
child developmental 
specialist provide WCC 
in partnership) + 

















Outcomes: 1 RCT: group 
well child care: 67% 
fully immunised and 
individual well child 
care 73% fully 
immunised, significance 
not reported; 1 RCT: 
33% of intervention 
group fully immunised 
compared to 18% of 
control group (p 
=0.011); 1 study (with 6 
RCT sites): adjusted ORs 
for being up-to-date 
with immunisations 
1.59 (95% CI 1.27–1.98); 
1 quasi-experimental 
comparison: adjusted 
ORs for being up-to-
date with 
immunisations 1.06 
(95% CI 1.02–1.09) 
 
Results on inequalities: 
Not reported, although 
one study directly 
targeted mothers living 






all studies not 
peer-reviewed so 
may have missed 
relevant literature 
and is potential 
for publication 
bias. Omitted 
tools that did not 
alter the delivery 
of WCC services 
(eg, handheld 
patient records) 
and tools that 
focused on clinical 
practice redesign 




















care centers, home 
visits], and 
alternative formats 
[eg, group visits, 
Internet]) that may 
affect receipt of 




overall quality of 
WCC" (p.S6) 
Review design: SR 







Evaluated a quality 
improvement process 
without identifying a 
specific change to care 
delivery; Addressed 
only 1 topic within 
WCC (eg, car-seat 




guidance); Focused on 
changes to WCC 
content or screening 
without addressing 
changes in the 
delivery of services; 
Evaluated 
interventions 
designed solely to 
increase compliance 
with or use of typical 
WCC 
 
Number of studies 
included: 33 
 
Number of relevant 














/ description: Not 
reported 
Sample sizes: 220-1593 
 






difficult to isolate 






s for future 
research: A 
review with a 
different set of 
criteria or fewer 
criteria for article 
inclusion could be 
helpful in giving 
paediatric 
practices a 
broader range of 





and potential cost 
savings and a 
commonly 
defined set of 

































F., Emmert, M., 
Scheppach, M., et 
al., 2013. Effects of 
pay for 
performance in 







Aim of the review: 
"to what extent 
has P4P [pay-for-
performance] been 





P4P have been 
observed? To what 
extent has P4P (4) 
Databases and 
websites searched: 
Medline, Embase, ISI 









Searched Internet via 
Google (specifics not 
provided), contacted 







including study type, 
country: 1) written in 
English, Spanish, or 
German 2) published 
between January 2000 

































description: Increase in 
payment for reaching 
target; relatively small, 
implicit incentives 






















Outcomes: 1 RCT: 
relatively small 
payments improved 
immunization rates by 
four percentage points 
(sig NR); 2 studies: 
classified as ineffective 
that found that 
increased immunization 
rates were largely due 
to better 
documentation, 
whereas other review 
classified them as 
effective; 1 RCT: mean 
immunization rates was 
six percentage points 
higher than the mean 
rate in the control 
group and the median 
change was higher in 
the intervention group: 
10.3% versus 3.5% (sig 
NR); 1 RCT (increase in 
fees for reaching 
target): the mean 
vaccination rate was six 
percentage points 
higher in the 



































inequalities in the 
quality of care and 















covering at least 1 of 










Exclusion criteria: 1) 
overview articles that 
were not systematic 
reviews 2) reviews 
that did not address at 
least one of the six 
domains 3) reviews 
only aimed to identify 
studies evaluating the 
effect of implicit 
financial incentives 
and/or studies 
evaluating the effect 
of explicit financial 
incentives, only 
focused on financial 
incentives for patients 
4) empirical studies 
with original 
quantitative or 
qualitative data on 
P4P effect(s) 5) 




NR); 2 studies (1 RCT 
and 1 TS): target 
payments associated 
with higher 
immunization rates, but 
the increase was 
significant in only 1 
study; 5% improvement 
overall, but much 
variation: positive 
effects found especially 
for immunizations, 
diabetes, asthma, and 
smoking cessation;1 
RCT: neither feedback 
alone nor ‘feedback + 
P4P’ improved 
childhood immunization 
rates (information from 
text) but information 
from supplementary file 
says "one study found a 
four percentage point 
improvement in 
immunization rates 
from baseline relative to 
the control group"; 
"One study found that 
P4P was associated with 
a seven percent 
increase in 







this may be a 
result of poorly 
reported primary 
studies as 




























overlapped by a 
subsequent review 
from largely the same 
authors 6) reviews 
that did not 
(consistently) report 
the methodological 
design of included 
studies 
 
Number of studies 
included: 22 reviews 
 
Number of relevant 
studies included: 8 
reviews 
Results on inequalities: 
Not reported in relevant 
studies, except in 1 
which stated: "No 




from 28 studies 
suggests reductions in 
inequalities in the 
quality of care across 
groups rather than 
increases" (Table 2), but 
immunisation rates 
were not the only 
outcome assessed in 
this study 
Sample sizes: Not 
reported 
 
Attrition details: Not 
reported 
impact on health 





quality of life. 
Insight is required 









setting in which 
the program was 
implemented and 
























Citation: Free, C., 
Phillips, G., Galli, L., 












10(1), e1001362.  
 
Aim of the review: 





delivered to health 







Health, The Cochrane 
Library, NHS Health 
Technology 
Assessment Database, 












including study type, 
country: Controlled 
trials; any mobile 
technology 
intervention to 
improve health or 





















to travel] >18 
years attending 
clinic for 








description: SMS (text 
message) reminder. 
"The travellers received 
the SMS a few days 
before the date 
foreseen, that is, for 
the reminder of the 
second hepatitis A+B 
dose, within 30 d of the 
primary dose, and for 
the second hepatitis A 
dose and the third 
hepatitis A+B dose 
within 6 mo of the 
primary dose." (p.13) 
Control/comparison/s


























but not for 
results relevant 
to this review 
 
 
Outcomes: RR 1.19 
(95% CI 1.15–1.23) 
Results on inequalities: 
Not reported 
 
Sample sizes: 2,349 
 












but very broad in 
scope and only 1 
of 75 studies 
































either mixed mobile 
technology and non-
mobile technology 
based interventions in 
which the treatment 
and control group 
both received the 
mobile technology-
based component or 
interventions in which 
treatments between 
the treatment and 
control groups 
differed in additional 
ways besides the 
components delivered 
by mobile technology" 
p.3 
Number of studies 
included: 75 
 
Number of relevant 
studies included: 1 
non-randomised 






























C., Scheel, I. B., 
Lewin, S., et al., 













Aim of the review: 
"to assess the 
effects of LHW [lay 
health workers] 
interventions on 
the uptake of 
childhood 
immunisation and 
to develop a 
Databases and 
websites searched: 
The Cochrane Central 
Register of Controlled 
Trials; MEDLINE, 













lists of included 
papers and relevant 
reviews; contacted 
authors of relevant 
papers regarding any 
additional published 
or unpublished work 
 
Years searched: 1950-
































families living in 
Intervention/s 
description: "LHWs 
made home visits to 
parents, giving them 
information about the 
importance of routine 
childhood 
immunisations and 
encouraging them to 
visit clinics for child 
immunisation" 
(p.1047); 3 studies: this 
information was given 
as part of a package of 
information and 
promotion about child 





/ description: Most 
studies: no 
intervention 1 study (in 
Turkey): LHWs making 
home visits were 
compared with 
midwives making home 
visits 1 study (in USA): 
Outcomes: 
'Immunisation 




















4 RCTs included in 
meta-analysis: 
intervention increased 
the number of children 
whose immunisations 
were up to date (RR 
1.19, 95% CI 1.09–1.30; 
P = <0.0001); 1 ITS 
"suggested an effect in 
favour of LHWs"; 1 RCT: 
"LHWs promoted 
immunisation uptake 
among mothers in a 
squatter area", "results 
not estimatable"; 1 RCT 
RR for African-
Americans 1.03 (95% CI 
0.91, 1.48); for 
Mexican-Americans 
0.87 (95% CI 0.76, 0.99); 
1 RCT no results 
presented  
 
Results on inequalities: 
Not reported 
 
Sample sizes: 244-3050 





to expand on 
































Review design: SR 
of mixed study 
designs (RCTs, 
nRCTS, controlled 










after studies, and 
interrupted time 
series (2) intervention 
targeted any person, 
including parents or 
community members, 
and where the aim 
was to increase 
immunisation 
coverage among 
children under 5 years 
of age (3) intervention 
delivered by LHWs 




carrying out functions 
related to healthcare 
delivery, trained in 
some way in the 
context of the 
intervention, and 


































validity score: + 
 
LHWs who made home 
visits and phone calls 
over a maximum of 6 
months were 
compared with study 
personnel making one 
home visit 
Attrition details: Not 
reported 
recommendation


















studies where LHWs 
were used as a 
substitute for trained 
health professionals 
or in addition to 
health professionals  
Exclusion criteria: (1) 
based outside of 
primary health care, 




studies that delivered 
interventions by LHWs 
with no intervention 
and standard care, or 
the same intervention 
delivered by health 
professionals 
Number of studies 
included: 12 
 
Number of relevant 
studies included: 8 (7 




















Citation: Holt, T.A., 
Thorogood, M. & 





available at the 






Aim of the review: 
"To synthesise 
current evidence 







available at the 









Index; ASSIA; EMBASE; 





Looked at reference 
lists of retrieved 
articles and past 







including study type, 
country: 
Controlled trials of 
reminder 


































[n=1] and paper-based 
[n=1] reminders 
provided that they 
were generated by 
electronic information 
specific to the 
individual in a health 
record and available at 





























Outcomes: Likelihood of 
achieving the desired 
outcome in the 
presence of a reminder 
influenza vaccination: 
OR 2.41 (95% CI 1.65, 
3.50) tetanus 
vaccination: OR 9.09 
(95% CI 6.44, 12.82) 
Total events: OR 4.69 
(95% CI 1.25, 17.53) (2 
RCTs) 
 
Results on inequalities: 
Not reported 
 
Sample sizes: Not 
reported 
 






effect sizes and by 
difficulties in 
synthesising data 




likely to depend 
on the health care 
setting, the 
detailed design of 
the reminder, and 
the priorities of 




may have missed 
some studies of 
more generalised 
decision support 
systems in which 
reminders were a 
minor element 
lack of detail 






Review design: SR 
and meta-analysis 
of controlled trials 
 
 
directed at clinician 
behaviour; available 







specific (rather than 
condition specific or 
drug specific) data 
non-randomised 
controlled trials 
included if data 




Exclusion criteria: BA 
studies (i.e. non-
comparative) 
Number of studies 
included: 42 in review, 
40 in meta-analysis 
 
Number of relevant 
studies included: 2 
RCTs 
reports over how 
the system 
actually operated 
in practice and 
what was 
required of the 






Only 2 studies 
















settings and users 











































care?: A systematic 





Aim of the review: 
"To evaluate the 














Literature Bank, New 
York Academy of 












including study type, 





































bonus systems for 
adherence to 
guidelines or meeting 
indicators (including 



























Outcomes: 1 RCT: 
change in percentage of 
children receiving 
recommended 
vaccinations over 1 y: 
control = -2.5 
percentage points; 
intervention = 5.9 
percentage points; p < 
0.05; 1 RCT: change in 
mean influenza 
immunization rates over 
1 y: control = 2.5 
percentage points; 
intervention = 10.3 
percentage points; 
p=0.03; 1 controlled BA 
(influenza vaccination): 
OR =1.79 (95% CI: 1.37–
2.35) [appears to be 
post test only]; 1 cohort 
study: adjusted relative 
risk (when P4P bonuses 
based on quality or 
patient satisfaction 
scores) = 1.06 (95% CI 
0.90–1.29), adjusted 
relative risk (when P4P 




author: Do not 












s for future 
research: Move 
beyond the simple 
examination of 
change in practice 
patterns to also 













SR of various study 










comparisons); had to 
compared P4P with at 
least 1 other payment 
model or compared 
performance before 
and after initiation of 
P4P on such quality-
of-care measures as 
target blood pressure 
or glycosylated 








provide payment to 
individual health care 
practitioners on the 
basis of their 
achievement of 
quality indicators in 
patients under their 
direct care 
 
Exclusion criteria: P4P 
programs aimed at 
hospitals or group 
practices; any process 
utilization or care costs) 
= 1.02 (0.89–1.14); 2 
uncontrolled BAs (MMR 
immunization): a) pre-
P4P = 78.1% (95% CI, 
73.9%–82.1%), post-P4P 
= 95.6% (95% CI, 93.5%–
97.7%) p < 0.001, b) 
pre-P4P = 83.2%, post 
P4P = 87.3% (year 2) 
and 81.8% (year 3), p = 
0.061 (year 2) p < 0.001 
(year 3); 1 uncontrolled 
BA (influenza 
vaccination) pre-P4P = 
57.4%, post-P4P = 
85.5%, p<0.05; 1 
uncontrolled BA 
(influenza vaccination) 
control = 47.1%, 
intervention = 81.3% 
Difference =34.2% (CI, 
33.4%- 35.0%) 
 
Results on inequalities: 
Not reported 
 
Sample sizes: 117 
physicians; 1943-
133,901 patients; two 
studies not reported 
 













care, and research 
into the effect of 
P4P schemes with 
these professional 
groups is urgently 
needed. 
Additional high-
quality research is 
required to fully 
evaluate the 
potential of P4P 
to affect patient 
care, outcomes, 










measures not related 
to patient outcomes 
(such as 
documentation of 
patient risk factors in 
their chart) 
 
Number of studies 
included: 30 (4 RCTs; 
5 ITSs; 3 controlled 
BAs; 1 nRCT; 15 
uncontrolled Bas; 2 
uncontrolled cohort 
studies) 
Number of relevant 
studies included: (2 
RCTs, 1 controlled BA, 



































J.C. & Szilagyi, P. 









Reviews. (1).  
 





or recall systems, 















Reference list of 
included articles and 
reviews; publications of 
abstracts, proceedings 
from scientific 






including study type, 
country: Study design: 
RCTs, controlled BAs, 
and ITSs; Participants: 









children (birth to 














Setting of included 
studies: "diverse 
settings, ranging 
from urban to 
rural, and public to 
private to 
university- based. 
Examples of study 
settings are state 
Intervention/s 
description: "Each 
intervention type was 
a mechanism to 
inform patients or 
families of the need 
for a vaccination that 
is due or overdue." 








postcard + phone 
combination (n=4); 




reminders (n=6). NB: 
adds up to more than 
47 because some 
studies had more than 
one intervention arm 
 
Control/comparison/s

































Patients receiving the 
patient reminder/ recall 
interventions were 
more likely to have 
been immunized or up-
to-date with 
immunizations 
compared with control 
subjects: pooled 
random effect model of 
34 RCTs: OR 1.57 
(95%CI: 1.41, 1.75), 10 
RCTs not included due 
to potential unit of 
analysis errors median 
OR 3.37, 3 controlled BA 
studies median OR 1.57; 
Routine childhood 
immunisation: pooled 
random effects (15 
RCTs) OR of 1.47 (95% 
CI: 1.28, 1.68), one 
eligible RCT study was 
excluded for a potential 
unit of analysis error OR 
6.79 (95% CI: 4.56, 
10.11); 1 CBA OR 4.11 



















either the patient 




unit of analysis 
errors from meta-
analysis. Lack of 
perfection in any 
study selected for 






of different types 





telephone), or a 
combination of 
both reminder 








BAs, ITSs)] with 
meta-analysis 
 
children (birth to 18 
years) or adults who 
receive immunizations 
in any setting; 
Interventions: patient 
reminder or recall 
interventions, or both, 
that either reminded 
patients of upcoming 
immunizations or 
immunization visits that 
were due (reminders) 
or were overdue (recall) 
delivered in any 
manner; Outcomes: 
immunization rates, or 















studies that had been 














schools" (p.7) USA 
(n=36); Canada 
(n=5); Australia 
(n=2); New Zealand 








and infants (n=4) 
[but unclear what 
this means; only 2 
studies specify low-
income children]; 
patients over 65, 
with chronic illness 
or both (n=20); 














2 studies (1 

















CBA The other CBA non-
significant effect, (but 
the baseline rates 





random effects (4 RCTs) 





adult”): 6 studies 
vaccination increases 
ranged from 1.8 to 27.4 
percentage points 
(statistically significant 
in 5 studies); pooled 
random effects (3 RCTs 
adult pneumococcal, 
tetanus, or Hepatitis B 
vaccinations) OR 2.19 
(95% CI: 1.21, 3.99); 3 
eligible RCTs excluded 
due to potential unit of 
analysis errors median 
OR 13.32; Adults 
influenza 
immunisations: 18 
studies changes in 



























plans' databases.  
Any studies that 









Number of studies 
included: 47 (44 RCTs 
and 3 controlled BAs) 
 
Number of relevant 
studies included: 47 (44 












decrease to 47 
percentage point 
increase compared with 
the controls, with half 
of the comparisons 
exceeding a 15 
percentage point 
increase, pooled 
random effects (12 
RCTs) OR 1.66 (95% CI: 
1.31, 2.09); 6 eligible 
RCTs excluded due to 
potential unit of 
analysis errors median 
OR 3.08; Adolescent 
immunisations: 1 RCT 
OR = 1.14 (95% CI = 
0.98, 1.31); 
Effectiveness of 
different types of 
reminder or recall 
systems (6 types): (1) 
person-to-person 
telephone reminders 
OR = 1.92, 95% CI: 1.20, 
3.07; (2) letter 
reminders OR = 1.79, 
95% CI: 1.50, 2.15; (3) 
postcard reminders OR 
= 1.44, 95% CI: 1.09, 
1.89; 1 CBA OR = 4.11 
(4) autodialer OR = 1.29; 















95% CI: 1.09, 1.53; (5) 
postcard and telephone 
combined OR = 1.45, 
95% CI: 1.11, 1.89; (6) 
patient reminder and 
recall in combination 
with outreach OR = 
1.37, 95% CI: 0.98, 1.98; 
when results of four 
comparisons of patient 
reminder recall 
interventions combined 
with provider reminder 
were pooled, the 
effectiveness exceeded 
those of patient 
reminder or recall 
systems alone OR = 
3.65, 95% CI: 1.54, 8.67; 
1 CBA OR = 1.32 
 
Results on inequalities: 
Not reported 
 
Sample sizes: 96-24,743 
patients 1 controlled 
BA: 4 clinics and 9 
communities 
 
Attrition details: Not 
consistently reported; 

























R., Wake, B., 




workers (HCW) to 
reduce influenza-
related outcomes 
in high risk 
patients: A 
Systematic review 
of clinical and cost-
effectiveness.  
 Department of 
Public Health and 
Epidemiology. 
Report Number 48. 
 
Aim of the review: 
"to review 
systematically the 











Specific internet sites 
such as PHLS, CDC 
Atlanta, Internet 
Search Engines – 
including Lycos, 
Copernic and Yahoo, 
citation lists, 
contacting clinical 
experts, registers of 
trials found on the 
internet 
Years searched: 1966-
January 2003 (for 
MEDLINE); updated 
Medline and Embase 
searches in 2004 
 
Inclusion criteria, 
including study type, 
country: Population: 





a health care 
setting such as a 
hospital or 
























description: 1. Letter 
+/- Public health nurse 
visit & promotion 2. 
Letters and interviews 
and local vaccination 3. 
Information sessions, 
posters, memos and 
vaccination clinics. 4. 
Mobile clinic ‘needles 
on wheels’ 5. Whole 
hospital: Adverts, 
newsletter personal 
letters; 3 Targeted 
departments: 
educational 
conference, visit by 
special health nurse 6. 
Educational 
intervention & ‘Staff 
vaccination fair’ with 
vaccine offered 7. In-
service meetings, video 
tapes and pamphlets 
 
Control/comparison/s
/ description: No 
campaign (for the 3 


















Outcomes: 2 cluster 
RCTs: 5.4% and 45% 
differences [at post-
test?] in favour of 
intervention group (sig 
NR); 1 nRCT:  effect-
adjusted odds ratio of 
2.8 (95% CI 1.4-5.8); 4 
non-comparative BAs: 
range 16%-46% increase 
in uptake rates (sig NR 
for any). 
 
Results on inequalities: 
Not reported 
 
Sample sizes: 195-5,514 
(one study not 
reported) 
 


















































RQs: "1. Does 
vaccinating 
healthcare workers 
protect the high 
risk group? 2. Is 
vaccination of the 
healthcare workers 
protective to the 





vaccination? 4. Will 
healthcare workers 
agree to have the 
vaccination? 5. 
What is the best 
within a health care 
setting such as a 
hospital or nursing 
home or community 




programme i.e. a 





programme (i.e. HCW 
may still be vaccinated 
of own accord), this 
may be a placebo 
programme; 
Outcomes: outcomes 



























a health care 
setting such as a 
hospital or 
















method to achieve 
optimal uptake 
rate? 6. Is 





Review design: SR 













Number of studies 
included: 28 (15 
interventional studies 
and 14 observational 
studies; 1 study had 
both parts) 
Number of relevant 
studies included: (2 
cRCTs, 1 BA with 





















J., Synnot, A., 
Ryan, R., et al., 










Reviews. 5.  
 
Aim of the review: 
"To assess the 
effects of face to 
face interventions 













Health, Gloabl Health 
Library (includes 








Clinical Trials Registry 
Platform (ICTRP - 
searched August 2012) 
and contacted authors 
to obtain further 
information or eligible 
data if available; The 
Grey Literature 
Report; OpenGrey; 
reference lists of all 
included papers and 
any key papers in the 





than 1 year) or 
preschool-aged 
children (1 to 5 






role, alone or in 
groups, 
targeted to 




who have at 
least one child 










structured home visits, 
each 1-2 hours long by 
research midwife to 
improve the rate of 
breastfeeding, 
immunisation and 
parental drug use 
among illicit drug-using 
mothers and their 
infants; 8 home visits 
occurring post-partum 
at weeks one, two and 
four, and monthly up 
to six months Vaccine 
focus: DPT, OPV, Hib 




Telephone contact at 2 
months and home visit 















outcome at six 
months after 
birth, at the 












effect on immunisation 
rates: RR 0.67 (95% CI: 
0.33 to 1.35) 
 
Results on inequalities: 
Not reported 
 
Sample sizes: 152 
 
Attrition details: 















query the decision 
to not extract 
vaccination 





















Review design: SR 
of RCTs and cRCTs 
 
Science (both the 
Social Science Citation 
Index and the Science 
Citation Index) and 
Google Scholar for 
papers that cited the 
studies included in the 
review; contacted 
authors of included 
studies and 
vaccination experts 
from the COMMVAC 
project advisory group 
and asked for 
additional references; 
asked authors of 
included studies to 
identify any economic 
evaluations conducted 





including study type, 
country: Study design: 
RCTs and cluster RCTs; 
Participants: Children: 
infants (less than 1 
year) or preschool-
aged children (1 to 5 
























mother was an 
adolescent, the 
mother was in 
jail, a fetal 
death occurred 





























parents, guardians or 
others fulfilling the 
parental role, alone or 
in groups, targeted to 
receive face to face 
information or 
education, and who 
have at least one child 
due or overdue for 
childhood 
vaccinations, 
Participants may also 
be expectant parents, 
who are individuals or 
couples currently 
pregnant, considering 
adoption or otherwise 
expecting to become 
guardians of a child, 
Vaccine program 
organisers: anyone 










to parents to inform 














median age 27 
for intervention 






















delivered by anyone 
including physicians, 
nurses, or other 
healthcare 
professionals, trained 
volunteers, lay health 
workers, members of 
the community, peers,  
or health visitors; 
Outcomes: 
Immunisation status 
of child (ie 
immunisation status 
up-to-date, or receipt 
of one or more 





to vaccinate child, 
Parent experience of 




Exclusion criteria: Not 
reported 
 







previous year (n 
= 149): < 
$20,000 
(67.5%); $20, 


















included: 7 studies (6 
RCTs, 1 cRCTs) 
 
Number of relevant 






















M., Haines, A., 
Palmer, N., et al., 
2009. The impact 
of conditional cash 
transfers on health 
outcomes and use 
of health services 





Reviews. 4.  
 
Aim of the review: 




in low and middle 
income countries 
to improve the 
health outcomes 












Register of Controlled 
Trials (CENTRAL), The 
Database of Abstracts 
of Reviews of 
Effectiveness and the 
EPOC Register (and 
the database of 
studies awaiting 
assessment), BLDS, 
ID21, ELDIS, The 






































enrolled received two 
types of cash transfers: 
universal (dependent 
on attendance at 
health facilities for all 
family members) and 
specific (associated 





/ description: Not 
reported 
Outcomes: 






text and results 












Outcomes: 1) After 6 
months: 1a) percentage 
of children under 12 
months old (at baseline) 
vaccinated for TB: 
relative treatment 
effect (adjusted 
difference in percentage 
points between 
intervention and 
control): 5.2 (p<0.01) 
1b) percentage of 
children 12-23 months 
old (at baseline) 
vaccinated for measles: 
relative treatment 
effect = 3.0 (p<0.05) 2) 
After 12 months: 2a) 
percentage of children 
under 12 months old (at 
baseline) vaccinated for 
TB: relative treatment 
effect = 1.6 (not 
significant) 2b) 
percentage of children 
12-23 months old (at 
baseline) vaccinated for 
measles: relative 









Only 1 relevant 
study. Review 
specifically aimed 






s for future 
research: Cost 
effectiveness 
studies to see if 
providing schools 
and health care 














Review design: SR 













BDSP, USAID database 
(Medline included in 
the appendix, but not 
in the list of databases 
searched); Websites: 
UNICEF, USAID and 
the World Bank, 
Partnerships for 
Health Reforms, Abt 
Associates, 
Management Sciences 
for Health (MSH), 
Oxford Policy 
Management, Save 
the Children, Oxfam, 
and a number of other 
networks or 
organisation websites 
such as The Private 
Sector Partnerships-
One, the Indian 
Council for Research 
on International 
Economic Relations, 
Equinet - The Network 
for Equity in Health in 
(not significant) 
Results on inequalities: 




Sample sizes: 506 
communities 
 









CCT may be 
effective. Relative 
effect of CCTs for 
different levels of 
incentives or 
different socio-
economic groups  
Source of 






Southern Africa, the 
Organization for Social 
Science Research in 
Eastern and Southern 
Africa (OSSREA), 
Institute of Social 
Studies, The Hague, 
the University of 
Southampton, the 
International Centre 
for Diarrhoeal Disease 
Research and the 
Centre for Health and 
Population research, 
Dhaka, the Boston 
University Institute for 
Economic 
Development, Harvard 
Initiative for Global 
Health, Cornell Food 




(University of Sussex), 
the London School of 
Hygiene and Tropical 
Medicine (HEFP 
website), the Institute 
of Policy Analysis and 






Research Unit of the 
University of Cape 
Town, the Netherlands 






contacted authors of 
relevant papers or 
known experts in the 







2009 (for Medline) 
 
Inclusion criteria, 
including study type, 
country: Study design: 
RCT, cRCT, controlled 
BAs (for RCTs, cRCTs, 
BAs: if comparison 
intervention was the 
provision of the same 
type of health services 






incentives to the 
populations to come 
and use health 
services) or ITS (if the 
point in time when the 
intervention/change 
occurred was clearly 
defined; there were at 
least three or more 
data points before and 
after the 
intervention); low and 
middle income 
countries (as defined 
by World Bank); 
populations that 
would potentially 




direct cash transfers 
conditional on a 
certain behaviour or 
outcome; outcomes: 
changes in use of 
health services and 
changes in health 
outcomes, health care 
expenditures and 
outcomes reflecting 




access (all measures 
had to be objective) 
 




travelled or travel 
time (as an outcome); 
Outcomes measured 
by description of 
attitudes, beliefs or 
perceptions 
Number of studies 
included: 6 (4 RCTs, 2 
controlled BAs) 
 
Number of relevant 
studies included: 1 
cRCT (of which one 
report out of 5 reports 


















































Expanded (Web of 
Science), Database of 
Abstracts of Reviews 




Register of Controlled 





Keyed the titles of 
relevant articles into 
the PubMed “related 
articles” feature to 
identify similar reports 
 
Years searched: 1950-
2009 (for Medline) 
 
Inclusion criteria, 





































access to the vaccine, 
legislation or 
regulation, and/or role 
models; Hospital 
settings: education or 
promotion, improved 
access to the vaccine, 
measurement with 
feedback, and 
legislation or regulation 
detail on each 
intervention provided 
in Table 2 
Control/comparison/s
/ description: Varied: 
no intervention; 




vaccination cart Table 2 

































hospital settings (4 
cRCTs and 1 BA, 9 
comparisons): 8 of the 9 
campaigns the health 
care personnel in the 
intervention groups 
were more likely to be 
vaccinated than those in 
the control groups (for 
successful campaigns 
RRs ranged from 1.80 
(95% CI: 1.33-2.43) - 
8.05 (95% CI 6.30-
10.30); unsuccessful 
campaign (cRCT) RR 
1.04 (95% CI 0.81-1.35); 
Campaigns with more 
components had higher 
risk ratios (i.e., 
favouring the 
intervention group). 
Hospital settings (7 
studies—2 RCTs, 3 BAs 
with controls, 2 ITSs, 16 
comparisons): mixed 
results: 3 of 8 (from 1 














had several risks 
of bias that might 
have generated 
misleading 






groups. Did not 





























for health care 
personnel (organized 
efforts to promote 
greater vaccination 
coverage among staff 
members 2) had to 
report the percentage 
or number of health 
care personnel who 
received the influenza 







studies (at least one 
comparison group, 
with one observation 
point before and 
another point after 
implementation of the 
intervention) and 
interrupted time 
series (clear time 
point at which the 
intervention was 
implemented; 









































alone the results 
showed sig intervention 
effect (for successful 
campaigns RRs ranged 
from 1.11 (95%CI 1.02-
1.21) - 2.71 (95% CI 
1.53-4.81)); 1 BA 
showed sig adverse 
effect (RR 0.86 (0.80-
0.92)); 4 showed no sig 
effect (from 2 RCTs) 
(RRs from 1.03 (0.80-
1.32) - 1.78 (0.80-3.96)); 
2 of 3 comparisons 
involving campaigns 
with educational or 
promotional 
components combined 
with improved access to 
the vaccine staff in the 
intervention group were 
more likely to be 
vaccinated than those in 
the control group (for 
successful campaigns, 
RRs: 1.64 (95% CI 1.49-
1.80) and 1.20 (95% CI 
1.11-1.30) (from 2 BAs); 
for unsuccessful 
campaign (1 BA) RR 1.13 
(95% CI 0.98-1.31) ; 2 





































have been recorded 
or, for studies with a 
shorter duration, a 
minimum of three pre- 
and post-intervention 
points must have been 
recorded) 
Exclusion criteria: 
1) studies that did not 
describe the study 
population or did not 
report ascertainment 
of vaccination status 
2) studies involving 
other vaccines (other 
than seasonal 
influenza) 
Number of studies 
included: 12 (2 RCTs, 4 
cRCTs, 4 BAs with a 
control, 2 ITSs) 
 
Number of relevant 
studies included: 12 (2 
RCTs, 4 cRCTs, 4 BAs 
with a control, 2 ITSs) 
or regulation 
components were 
integrated into the 
overall campaigns: 




increased to 55% 
(previous 9 years rates 
ranged from 21% to 
38%), when 
unvaccinated personnel 
were required to wear 
masks vaccination rates 
increased from 33% to 
52% (significance not 
reported) All RRs 
presented in Figure 2, 
p.E547 
 
Results on inequalities: 
Not reported 
 
Sample sizes: 141-7,747 
Attrition details: Not 
reported 





































Citation: Lau, D., 
Hu, J., Majumdar, 
S. R., Storie, D. A., 
Rees, S. E., 








dwelling adults: a 
systematic review 
and meta-analysis. 















Scopus, Web of 
Science, AARP Ageline, 
PsychInfo, Social 







from previous reviews 






including study type, 
country: 1) English 
language studies 2) 
published in peer-
reviewed journals 3) 
elderly adults or 
adults with chronic 

































description: Audit and 









similar) (n=9); Delivery 






(n=72); Team change 
(n=26); Visit structure 
change (n=1) NB: 
detailed description of 






























Outcomes: Pooled odds 
ratio for effectiveness of 
all quality improvement 
interventions  for either 
vaccination was 1.61 
(95% CI, 1.49-1.75; P 
<.001; I2 = 85% -
influenza vaccination: 
pooled across all 
interventions (65 
studies, 93 
comparisons) OR was 
1.46 (95% CI, 1.35-1.57; 




rates (ORs and 95% CIs): 
a) community 
engagement (2 
comparisons from 1 CCT 
and 1 cluster CBA) 3.00 
(1.28-7.03); b) visit 
structure change (1 
comparison from 1 CCT) 
2.44 (1.42-4.20); c) 
financial incentives-
patient (5 comparisons 
from 3 CCTs and 1 





which may have 
led our pooled 
odds ratios to be 
overly optimistic. 
Did not address 
the economic 




generalize well to 
nonelderly adults 









reporting flaws in 
the included 















Review design: SR 






featured a parallel 
control group 6) 
reported influenza or 
pneumococcal 
vaccination rates 7) 
community setting 8) 
sufficient data to 
estimate log odds 
ratios (ORs) and 
standard errors 
Exclusion criteria: 
Studies taking place in 




Number of studies 
included: 77 (56 RCTs 
or quasi-RCTs; 7 
controlled before-
after studies; 12 
observational studies) 
[only adds up to 75] 
Number of relevant 
studies included: 77 
(56 RCTs or quasi-
RCTs; 7 controlled 
before-after studies; 
12 observational 
studies) [only adds up 
studies at non-
clinical sites 
















validity score: + 
 
 
2.56); d) audit and 
feedback (4 
comparisons from 2 
cluster RCTs and 1 
prospective cohort) 1.83 
(1.28-2.61); e) case 
management (4 
comparisons from 2 
RCTs, 1 CCT, 1 
retrospective cohort) 
1.66 (0.81-3.43); f) 
clinical reminders (30 
comparisons from 8 
cluster RCTs, 4 CCTs, 3 
RCTs, 2 prospective 
cohorts, 3 retrospective 
cohorts, 1 cluster 
prospective cohort, 2 
CBAs, 1 cross-over 
cluster RCT) 1.53 (1.26-
1.85); g) financial 
incentives-clinical (3 
comparisons from 1 
CCT, 1 RCT, 1 CBA) 1.52 
(1.20-1.93); h) team 
change (20 comparisons 
from 3 retrospective 
cohorts, 1 prospective 
cohort, 1 CBA, 3 CCTs, 6 
cluster RCTs, 4 RCTs, 1 
cluster prospective 
cohort) 1.44 (1.16-1.79); 










some cases this is 
recoverable from 
evidence tables, 
but can’t be 
readily 
reintegrated into 




















to 75] comparisons from 16 
CCTs, 8 RCTs, 2 
retrospective cohorts, 1 
prospective cohort, 9 
cluster RCTs, 3 CBAs, 1 
cluster CBA, 1 cluster 
prospective cohort) 1.42 
(1.30-1.55); j) delivery 
site change (6 
comparisons from 3 
cluster RCTs, 1 CCT, 1 
CBA) 1.32 (1.14-1.52); k) 
continuous quality 
improvement (2 
comparisons from 1 
cluster RCT and 1 
cluster CBA) 0.99 (0.94-
1.04); l) clinical 
education (8 
comparisons from 1 
RCT, 3 cluster RCTs, 1 




across all interventions 
(35 studies, 48 
comparisons) OR was 
2.01 (95% CI, 1.72-2.36; 





























author: AI-HS; last 
author: AI-HS and 
holds a Canada 








vaccination rates (ORs 
and 95% CIs): a) 
financial incentives-
clinical (1 comparison 
from 1 RCT) 7.43 (2.25-
24.53); b) visit structure 
change (1 comparison 
from 1 CCT) 2.25 (1.30-
3.92); c) clinical 
reminders (27 
comparisons from 10 
cluster RCTs, 2 
prospective cohorts, 3 
CCTs, 2 RCTs, 2 cluster 
CBAs, 1 retrospective 
cohort, 1 CBA) 2.13 
(1.50-3.03); d) team 
change (14 comparisons 
from 3 RCTs, 5 cluster 
RCTs, 2 CCTs, 1 
prospective cohort, 1 
retrospective cohort) 
2.09 (1.48-2.95); e) 
continuous quality 
improvement (2 
comparisons from 1 
cluster RCT and 1 
cluster CBA) 1.86 (0.66-
5.21); f) patient 
outreach (26 
comparisons from 6 
CCTs, 5 cluster RCTs, 3 
RCTs, 1 cluster CBA, 1 
Wellness and a 
CIHR Team Grant 






sponsored by the 









cohort, 1 retrospective 
cohort, 2 prospective 




comparisons from 1 CCT 
and 1 cluster 
prospective cohort) 1.78 
(1.00-3.17); h) delivery 
site change (1 
comparison from 1 
prospective cohort) 1.66 
(1.59-1.74); i) clinical 
education (7 
comparisons from 1 
CCT, 2 prospective 
cohorts, 2 cluster 
CRCTs, 1 RCT) 1.54 
(1.19-1.99); j) case 
management (3 
comparisons from 1 
CCT, 1 RCT, 1 
retrospective cohort) 
1.49 (1.05-2.13); k) 
audit and feedback (3 
comparisons from 2 
cluster RCTs, 1 
prospective cohort) 1.18 
(0.57-2.45) NB: results 
of meta-analyses within 




outreach and team 
change also available, as 
well as numbers needed 
to treat 
 




134,791 (most, but not 
all studies' sample sizes 
reported) 
 
Attrition details: Not 
usually specified, but 
available for some 




















Citation: Lewin, S., 
Munabi-
Babigumira, S., 
Glenton, C., et al., 
2010. Lay health 
workers in primary 
and community 
health care for 
maternal and child 






Reviews. 3.  
 
Aim of the review: 
"To assess the 
effects of lay 
health worker 
interventions 
[LHW] in primary 
and community 




EPOC and Consumers 
and Communications 
Group trial registers); 
MEDLINE; MEDLINE In-
Process; EMBASE; 






Reference lists of 
included studies and 
relevant reviews; 
contact with authors 
of included studies; 
studies citing included 
studies (on SCI / SSCI) 
Years searched: 1950-




including study type, 
country: Study type: 
































visiting, reminders for 
vaccination, various 
social and practical 
support, guidance on 
accessing services and 
preventive health. One 
intervention also 




involved training of 




/ description: Most 





















effect size (6 RCTs): RR 
1.23, 95% CI 1.09 to 
1.38; P = 0.0006. (One 
RCT excluded from this 
analysis as did not 
present data.) 
Results on inequalities: 




Sample sizes: 244-3,050 
 
Attrition details: Not 


































maternal and child 









any lay health worker 









all; Type of 
intervention: any 
delivered by a LHW 
and intended to 
improve maternal or 







utilisation, process of 
care, satisfaction with 
care, costs, social 
outcomes 
Exclusion criteria: Any 
intervention delivered 
by a formally trained 
health professional, 
patient support groups 
studies: 
children <2, 














living in local 
authority 
housing; people 


















different forms of 
LHW training; 





















only, teacher- or peer-
led programmes in 
schools, interventions 
delivered by trained 
family members; 








a comparison allowing 
assessment of the 
LHW component 
Number of studies 
included: 82 RCTs 
 
Number of relevant 
studies included: 7 
RCTs 
thirds in receipt 
of Medicaid 
External 























A., O'Connell, D., 




to patients: how 
they are expressed 
makes a 
difference. Journal 
of General Internal 
Medicine. 18(11), 
948-959.   
 
Aim of the review: 







Review design: SR 











lists; "Social Science 
Citation Index and 
Science Citation Index 
were examined for 
articles citing 
prominent authors 
who had published 
articles on framing." 
 
Years searched: 1966 - 




including study type, 
country: 1) Published 
in English; 2) Assigned 
participants to a 
framing condition, 
such as positive (or 
















































Outcomes: "No effect", 
full outcome data NR 
 
Results on inequalities: 
Not reported 
 
Sample sizes: Not 
reported 
 







Pooled effect size 

































included; 3) Used a 
verbal or numerical 
frame format. Articles 
analyzing the effect of 
graphical displays on 
decision making were 
excluded; 4) Described 
patients and/or 
volunteers making 
either real or 
hypothetical personal 
treatment decisions or 
evaluation 
 
Exclusion criteria: Not 
reported 
 
Number of studies 
included: 40  
 
Number of relevant 





































S.M., Hopkins, D.P., 






and hepatitis B 
vaccination 
coverage among 







Aim of the review: 





























including study type, 
country: (1) published 
between 1980 and 
August 2001 as a 
journal article in 




risk (defined as 
people with a 



















people with >1 
sexual partner 
in previous six 
months; 
prisoners; 
clients and staff 
Intervention/s 
description: Clinic-
based client education; 
client reminder 


































client education (n=2): 1 
cRCT increases of 2 and 
10 percentage points (2 
different interventions) 
in proportion screened 
or vaccinated for 
hepatitis B; 1 RCT RR 




reminder systems (1 
RCT): self-reported 
vaccination for influenza 
improved by 3.7 
percentage points -
community education: 
no studies found -client 
or family incentives (1 
nRCT): hepatitis B 
vaccination amongst 





expanding access in 
healthcare settings: no 





was not stratified 
by targeted 






























with risk factors 
that make them 
particularly 
susceptible to a 
disease" (p.248) 
 
Review design: SR 










vaccinations in a 
population at risk, or 
included information 
on risk populations 
(subsets) as part of a 
larger vaccination 
effort; and (3) 
outcome 
measurements 
included changes in 
vaccination coverage 
 
Exclusion criteria: Not 
reported 
 
Number of studies 
included: 35 (15 RCTs, 
3 cRCTs, 2 non-
randomised trials, 2 
cluster non-
randomised trials, 3 
retrospective cohort 
studies, 6 time series 




































(n=7,4 RCTs, 2 
retrospective cohorts, 1 
TS) all influenza or 
pneumococcal 
polysaccharide vaccines; 
median improvement in 
vaccination coverage of 
17.9 percentage points 
(range -1 to 72) -
provider education: no 
studies found -provider 
assessment and 
feedback (1 TS) 
vaccination coverage 
among at-risk patients 
improved by 32 
percentage points for 
influenza vaccine and 18 




interventions (n=23): a) 
interventions combined 
within a single category 
of community demand 
(1 RCT) change in 
percentage points 
+13.6; b) interventions 
combined within a 






































comparison group)  
Number of relevant 
studies included: 35 
(15 RCTs, 3 cRCTs, 2 
non-randomised trials, 
2 cluster non-
randomised trials, 3 
retrospective cohort 
studies, 6 time series 


















based (n=1, other 
design with concurrent 
comparison) change in 
percentage points +11; 
c) interventions 
combined across two 
conceptual categories 
community demand and 
provider-or system-
based (n=5, 1 
retrospective cohort, 1 
RCT, 1 TS, 1cRCT, 1 
other design with 
concurrent comparison) 
change in percentage 
points +3.7 (range -2 to 
+28.9); d) interventions 
combined across two 
conceptual categories: 
community demand and 
enhanced access (n=9, 6 
RCTs, 2 other designs 
with concurrent 
comparison, 1 TS) 
median change in 
percentage points +14 
(range +3.1 to +46); e) 
interventions combined 
across two conceptual 
categories: provider- or 
system-based and 
enhanced access (n=3, 1 
TS, 1 group non-
and/or 
recommendation




















randomised trial, 1 RCT) 
median change in 
percentage points +27.8 
(range -0.5 to 31); f) 
interventions combined 
across all three 
conceptual categories 
(n=4, 1 group non-
randomised trial, 1 TS, 1 
cRCT, 1 individual non-
randomised trial) 
median change in 
percentage points +22.8 
(range -5.9 to +67) 
significance only 
reported for some 
individual studies (see 
Appendix A) 
 
Results on inequalities: 
Not reported 
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(2009). Reducing 





children and young 



















Applied Social Science 




(Cochrane Database of 
Systematic Reviews 
and the Database of 


















aged under 19 






of children and 
young people 







for children and 
young people 
aged under 19 












reminders (personal or 
automated) or a 





or trained community 
support worker visiting 
parents in their homes 
to discuss 
immunisation; Client or 
family incentives: 
payments (financial 
benefits) are linked to 
immunisation and 
schemes where 
parents are provided 




programmes in school 








OPV, Hib, Hep 





















systems: 1a) mixed 




children < 2 years not 
up-to-date with the 
recommended 
vaccination schedule: 
1st (postal reminder) NS 
difference in the 
proportion of babies up-
to-date with primary 




results depending on 
the age of the child (sig 
improvements in 
children over 12 
months, NS is children 
7-9 months); 3rd 
(automated telephone 
messages or letters 
alone or in 
combination) improved 
vaccination uptake 1b) 
Limitations 
identified by 
author: Lack of 
sufficient 





designs that were 
more prone to 
bias and/or 
confounding. 
Timeliness of the 
research reported 
(in terms of its 
relevance to the 
current context of 
immunisation in 
the UK) was 
somewhat 




General lack or 
recognition (or 
reporting) of the 








Aim of the review: 







that seek to 
reduce differences 
in the uptake of 
immunisations in 
children and young 
people aged under 
19 years" (p.40) 
 











Centers for Disease 
Control and 
Prevention, 
Department of Health, 
DIPEX-personal 
experiences of health 
and illness, European 




Evidence for Social 
Policy and Practice Co-
ordinating Centre, 
Health Evidence 
















































children to show proof 
of vaccination status 
for entry to school; 
routine checking of 
immunisation status by 
school nurses; delivery 
of vaccinations in the 
school setting; and 
educational initiatives 





education and training 
about vaccinations (e.g. 
in relation to the 
universal [routine] 
immunisation schedule 
and targeted vaccines 
such as Hep B and 
BCG), reminders to GPs 




Provision of child 
vaccination 
information to service 
providers; 
Opportunistic 
mixed evidence from 3 
RCTs of effectiveness of 
reminder/recall 
interventions targeting 
children aged 2-7 years 
not up-to-date with the 
recommended 
vaccination schedule: 
1st and 2nd ( telephone 
and postal reminders 
either alone or 
together) significantly 
more likely to be 
immunised or brought 
up-to-date; 3rd (postal 
reminders) not effective 
1c) 1 RCT review of 
medical records plus 
delivery of automated 
reminder telephone 
calls to families of 
young people aged 11-
14 years who were 
behind on vaccinations: 
significantly improved 
Hep B vaccination 
uptake, NS increase in 
uptake of Td booster 
uptake 1d) 1 RCT baby 
clinic for black, 
adolescent first-time 







in USA so may 
have limited 




review team: All 
studies described 
individually with 
large amounts of 
detail, overall 
hard to extract 
useful data on 
effectiveness for 





s for future 























Asked experts in the 







Asked members of 




2008 (but articles prior 





































intervention, but varied 
reminder calls and 
letters after missed 
appointments 
significantly increased 
the proportion of 
children who were up-
to-date for 
immunisations 1e) 
mixed evidence from 3 





families of low socio-












vaccination coverage in 
babies who were not 
up-to-date at baseline, 













improve uptake of 
DTP, Hib, PCV, 

















and young people 
aged under 19 years 




children and young 
people aged under 19 
years, health 
professionals and 
practitioners with a 
responsibility for 
children and young 
people aged under 19 




to reduce differences 
in the uptake of 
universal or targeted 
immunisations in 
children and young 




interest with a no-




calls) NS difference in 
number of children 
vaccinated within 1 
month of call 1f) mixed 
evidence 2 RCTs and 1 




children aged under 2 
years: 1st and 2nd (1 




uptake of DTP, OPV, Hib 
and MMR; 3rd RCT 
(health message or a 
message reminding 
parents that vaccination 
was compulsory) had NS 
impact on vaccine 
coverage 2) Home-visit 
interventions: 2a) 1 RCT 
home vaccination 
service for children who 














or decreased rates of 
initiation and/or 
completion of the 
recommended 
immunisation 








reduce differences in 
the uptake of 
immunisations and 
variations in cost 
effectiveness 
depending on how 
close the target 
population was to 
optimal uptake; 
impact on barriers to 
the uptake of 
immunisations; 
adverse or unintended 
outcomes of 
interventions to 
outreach home visits: 1 
BA study significantly 
improved children’s 
vaccination coverage; 1 
RCT (several visits and 
advise/support) as 
effective at ensuring 
age-appropriate 
immunisations 
regardless of whether it 
is delivered on a one-to-
one basis or a group 
basis 2c) 1 RCT 
(community outreach 
home visits and nurse 
visits for pregnant black 
and minority ethnic 
group) increased 
vaccination rates 
(significance levels not 
reported) in babies at 
12 months 2d) 1 RCT 




vaccination uptake at 
age 12 months; at 24 
months intervention 
group less likely than 






reduce differences in 
the uptake of 
immunisations; views 









reduce differences in 






method, timing and 
place of delivery, 











groups, including data 
large loss-to-follow up) 
2e) 1 RCT (regular home 
visits to new mothers 
who were illicit drug 
users NS increase age-
appropriate vaccination 
rates of newborns at 2, 
4 or 6 months 3) Client 
or family incentives: 3a) 
mixed evidence from 




increasing uptake of 
immunisations in 
children of low-income 
families: 1st RCT One 
RCT (linking receipt of 
benefit payments to 
proof of up-to-date 
immunisation) 
significantly increased 
immunisation rates; 2nd 
RCT and 3rd NRCT 
Conversely, two studies 
(welfare benefits or a 
personalised calendar) 
no improvement in 
vaccination uptake 3b) 1 
case-control study: 
children significantly 





quality of life of 
children and young 
people having 
contracted a disease 
being immunised 









analyses, RCTs, NRCTs, 
cohort studies, 
controlled before and 
after studies, before 







process or outcome 
evaluations, cost 
effectiveness analyses, 




immunised if parents 
were aware of, and had 






and child care benefit) 
4) Vaccination 
programmes in school 
(or day care 4a) 1 RCT 
(letters and follow-up 
phone calls) for pre-
school children not up-
to-date with their 
vaccinations was 
effective at increasing 
uptake of 
immunisations (but 
large loss-to-follow up) 
4b) 5 studies (2 BAs, 2 
cohorts, 1 cross-
sectional) that policies 
requiring vaccinations 
for school or day care 
entry are effective at 
increasing immunisation 
coverage: 1st BA 
significant increase in 
MMR and Hep B 





or costing studies  
Exclusion criteria: 1) 
published before 1988 
were excluded 2) non-
English articles 3) 
articles published as 
abstracts only 4) 
articles not held by the 
British Library 5) 
population: target 
population of those 
receiving 
immunisations was 
children and young 
people in developing 
countries or people 
aged at least 19 years 
6) interventions: 
setting of national 
immunisation 
strategies, policies, 
priorities and targets 
selective vaccination 
of young people at 
occupational risk of 
infection; selective 
vaccination of children 
and young people 




immunisation; 3rd and 
4th cohort studies 
found increase in Hep B 
coverage (but not other 
vaccinations in one 
study); 5th cross-
sectional found in states 
with day care entry 
requirements, 
significantly more 
children had received 
three or more doses of 
Hep B vaccine 
compared with states 
without an entry 
requirement; 1 cohort 
study policy was 
effective at reducing 
differences in coverage 
between different 
ethnic groups; 1 BA 
legislation requiring 
schools to ask that 
school immunisation 
certificates be provided 
as evidence of 
immunisation at the 
time of enrolment did 
not increase the 
number of students 
providing the 
certificate, although in 





of children and young 
people clinically at risk 
of infection with 
vaccine-preventable 
diseases as a result of 
underlying medical; 
interventions seeking 
to increase uptake of 
single-antigen vaccines 
for measles, mumps 




to be generalisable to 
the UK was found for a 
particular aspect of 
the review, older 
studies and/or those 
based on weaker 
methodological 
designs were excluded 
8) Articles that 
reported neither 
intervention studies 
nor outcomes relating 







proportion that were 
completely immunised 
increased significantly 
4c) 1 cRCT (school Hep 
B education 
programme) did not 
increase uptake of Hep 
B vaccine 5) Provider-
based interventions: 5a) 
4 studies (1 ITS and 
three BAs; education 
and training for health 
professionals in 
implementation of 
targeted neonatal BCG 
vaccination policies) 
were effective at 
increasing the 
proportion of at-risk 
neonates that received 
timely vaccination 5b) 2 
studies (1 ITS 1and 1 BA; 
provider reminder 
systems) effective at 
increasing the 
proportion of at-risk 
babies who receive BCG 
vaccination and the 
proportion of babies of 
low-income families 






Number of studies 
included: 155 
 
Number of relevant 
studies included: 103 
(DTP/OPV) within 
recommended 
timeframe 5c) 1 cRCT 
(‘continuing medical 
education’ programme) 




compared with control 
clinics (but likely 
confounding in study) 
5d) 1 BA study 




proportion of babies 
aged up to 24 months 
who were up-to-date 
with the recommended 
vaccination schedule 
5e) 1 cohort study 
(provider continuity) 
significantly more likely 
to be up-to-date with 
the recommended 
immunisation schedule 
by ages 7 and 12 
months 5f) lack of 
quantitative evidence 
on the effectiveness of 




on provision of provider 
incentives for increasing 
immunisation uptake; 8 
studies (all BA) 






found that the 
campaign resulted in 
higher practice 
coverage rates and an 
increase in age-
appropriate vaccination 
coverage 6) Provision of 
child vaccination 
information to service 
providers 6a) 2 studies 
(1 RCT and 1 BA) 
provision of 
immunisation status 
information alone, for 
children at-risk of being 
unimmunised or behind 
on the recommended 
immunisation schedule 
is not effective at 
increasing immunisation 
uptake; 1st RCT (non-
directive phone call) NS 




in the proportion of 
children aged under 2 
years who were brought 
up-to-date with their 
immunisation schedule; 
2nd BA (provision of 
detailed immunisation 
history to senior social 
service managers) for all 
looked after children 
registered with an 
authority was 
ineffective at increasing 
uptake of primary, pre-
school and school-
leaving booster 
vaccinations in these 
children 7) 
Opportunistic 
vaccinations 7a) 2 
studies (1 RCT and 1 





uptake; 1st RCT 
(marking notes with 
vaccine requirements 
for appointments for 
children aged 0-2 years) 





and vaccination of all 
children requiring 
vaccinations at every 
clinic visit) significant 
increases in the 
percentage of children 
age-appropriately 
immunised with 
intervention 7b) 7 




are effective for 
increasing uptake of 
recommended 
vaccinations in children 
admitted to hospital; 
1st RCT (hospital sent 
letter to primary care 
provider or vaccinated 




discharge, but NS; 2nd 
and 3rd BAs (hospital-
based vaccination) for 
children (aged 0-2 








the proportion of 
children who were age-
appropriately 
immunised and reduced 
the number of missed 
opportunities for 
vaccination; 4th BA 




number of vaccinations 
provided significantly 
increased in paediatric 
wards, but not 
emergency 
departments; 5th and 
6th BA (hospital-based 
vaccination ) some 
children were 
successfully brought up-
to-date with the 
recommended 
vaccination schedule, 
one study found that 
some carers refused; 
7th cohort (hospital-
based vaccination) for 
pre-school children not 






on admission to the 
emergency department 
significantly decreased 
on discharge after 
hospital-based 
vaccination, at 6th 
months difference NS 
7c) 2 NRCTs (verbal 
reminder, sometimes 
follow-up letter to 
primary care provider) 
for parents of children 
identified on admission 
to hospital as being not 
up-to-date with the 
recommended 
immunisation schedule 
was effective at 
encouraging vaccination 
within 30 days 7d) 1 
cohort study (Hep B 
vaccination offered at 
school) results in higher 
uptake compared with 
offering them in 
community settings 
during weekends and 
evenings 7e) 1 ITS (offer 
Hep B vaccination) for 
all injecting drug users 
(aged 16-20 years) who 







uptake 8) National 
immunisation 
programmes 8a) 9 
studies show evidence 
that multicomponent 
national immunisation 
campaigns are effective 
at increasing uptake of 
vaccinations; 8 BAs of 
campaigns showed 
higher practice 
coverage rates and an 
increase in age-
appropriate vaccination 
coverage; 1 BA (MMR 
campaign) increased 
MMR vaccination 
coverage from 87.4% to 
96.4%; 1 study (design 
not specified) coverage 
improved more in areas 
with low socio-
economic status 
compared with areas 
with high 
socioeconomic status 
and, that coverage 
improved along a 
gradient from highly 
accessible areas to 










children not up-to-date 
with vaccinations 
significantly increased 
completeness rates for 
the recommended 
vaccination series; 
completeness rates for 
those in the 
intervention group were 
also significantly higher 
for those who received 
a home visit 9b) 1 RCT 
(multicomponent 
intervention) not 
effective in increasing 
vaccination rates 9c) 
strong evidence from 10 




effective at increasing 
uptake of childhood 
immunisations; 4 RCTs 






the number of children 
who were up-to-date 
with the recommended 
vaccination series or 
who received 
vaccinations, at least in 
the short term (6 
months to 1 year); 1 
cRCT targeting children 
from black, low-income 
families, significantly 
improved uptake of 
immunisations to age 9 
months, NS difference 
at 12 months but large 
loss-to-follow up; 1 
NRCT One NRCT looked 
at two strategies 
amongst Vietnamese-
American parents and 
both significantly 
increased uptake of Hep 
B vaccine compared; 





immunisation uptake: 1 
RCT with 7 year follow-
up found NS difference 
between intervention 




the proportion of 
children that had 
received MMR or the 
school booster, 
although subsequent 
children of mothers in 
the intervention group 
were significantly more 
likely to have completed 






coverage rates 9d) 1 
RCT (multicomponent 
programme) for babies 
of black and minority 
ethnic group families 
did not improve 
immunisation rates 9e) 
2 studies show that 
targeted 
multicomponent 
programmes based on 
enhancing access to 









immunisations; 1st cRCT 
for children of low-
income families in need 
of vaccinations was 
effective at increasing 
the proportion of babies 
up-to-date with 
immunisations; 2nd ITS 
for children who were 
further behind in 
immunisations 
significantly increased 
immunisation rates in 
city and suburban 
settings from baseline 
after 3 years, although 
after 6 years the 
increase was no longer 
statistically significant 
9f) 1 BA study 
significantly increased 
uptake after the postal 
reminders were sent of 
DTP and Hib among 
children aged more 
than 6 months living in 
a deprived area 9g) 1 BA 
study for homeless and 
runaway young people 








dose Hep B vaccination 
schedule; 1 cohort 
study for 137 rural 
families was not 
effective at increasing 
vaccination uptake in 
these children 10) cost-
effectiveness of 
reminder/recall systems 
10 a) 8 studies 
concluded that 
reminder/recall 
systems, and especially 
automated systems, 
were cost effective, but 
with significant 
limitations in the 
studies (therefore, a 
lack of evidence in 
relation to cost 
effectiveness of 
reminder/recall systems 
for reducing differences 
in the uptake of 




interventions: 11a) lack 
of evidence in relation 






to reduce differences in 
the uptake of 
immunisations in low-
income population 
subgroups in the UK NB: 
have not reported 
results for specific 
groups of vaccinations 
(e.g. MMR), have 
focused instead on the 
different types of 
interventions  
 
Results on inequalities: 
Frequently describe the 
results for low-income 
and/or minority groups 
(these have been 
reported in the results 
where appropriate) 
 
Sample sizes: 30-1.78 
million 
 
Attrition details: Varied 




















Citation: Scott, A., 
Sivey, P., Ait 
Ouakrim, D., et al., 
2011. The effect of 
financial incentives 










Aim of the review: 
“to examine the 
effect of changes 
in the method and 
level of payment 
on the quality of 
care provided by 
primary 
care physicians 





EconLit, PAIS, EPOC 
Group Specialised 
Register, The Cochrane 
Library, all sections 
including DARE 
(Database 
of Abstracts of 
Reviews of 





Central Register of 
Controlled Trials 
(CENTRAL), Internet-






Economics) and the 
Social Science 
Research Network 
































description: GPs could 
choose to directly 
contract with local 
health organisations 
and to switch from 
capitation to salaried 
contracts (Personal 
Medical Services) ; 




/ description: Control 
GPs stayed under 
General Medical 
Services (GMS) 
scheme, a standard 
national contract; not 




































95.96 (sd=2.24), control 
(post)= 92.48 (sd=6.10),  
Absolute difference = 
3.48, relative % change 
= 3.76%, absolute 
change from baseline 
intervention = -2.63% 
control = -1.55%, 
difference in absolute 
change from baseline = 
-1.08%. 1 controlled BA 
and ITS, childhood 
immunisation rate: 
Difference in trend 
(ITS): 
Intervention group 1 
(QIP) =  -0.471 
(s.e.=0.385), 
intervention group 2 
(IHA1+QIP2) = -1.092 
(s.e.=0.485), difference 
in absolute change 
Limitations 
identified by 
author: The use of 
a different 
geographic area 
as the control 
group may have 
meant that 
that populations 
of patients and 
physicians 




could be different 
and be 
correlated with 





that had data for 
the entire period 
were included in 
analyses, 
thus suggesting 






Review design: SR 






websites of key 
organisations: 
UK - National Primary 
Care Research & 
Development Centre, 
NHS Service Delivery 
and Organisation R&D 
Programme, NHS 
Centre for Reviews 
and Dissemination; 
USA - Commonwealth 
Fund, Robert Graham 
Centre; 
Europe - European 
Observatory on Health 
Systems and Policy; 




Australia - Primary 
















score:  ̶ 
 
 
from baseline (CBA): 
intervention group 1 
(QIP) = 3.155 (s.e.= 
1.365), intervention 
group 2 (IHA1+QIP2) = 
2.078 (s.e.=1.196) 
 
Results on inequalities: 
Not reported 
 
Sample sizes: 20 GP 
practices (10 
intervention; 10 
control), 172 large 
medical groups  
 









review. Only two 
studies of 
relevance to 





s for future 
research: More 
rigorous study 
designs need to 
be used that 
















position papers and 
policy statements of 
professional bodies or 
associations identified 
through key 
informants and policy 
contacts; previous 
research conducted by 
the review authors, 
personal contacts in 
the area, professional 
and academic experts 
in the field, an 
advisory committee of 
experts from Australia, 
















the method of 
payment between one 
theoretical basis, 
a broader range 







describe i) the 
type of payment 
scheme at 
baseline or in the 
control group, ii) 
how payments to 
medical groups 
were used and 
distributed, and 
iii) the size of the 
new payments as 












of the following: a. 
payment per unit of 
time (salary, sessional 
payment), b. payment 
for each  service, visit, 
treatment, or episode 
provided 
(fee-for-service), c. 
payment for each 
patient enrolled or 
registered with the 
PCP (capitation), 




changes who is paid 
(e.g. from an individual 





Outcomes: quality of 
care provided 
by PCPs that were 
related to patients’ 


















care teams, patients 
being treated by 
primary care 










Number of studies 
included: 
 
Number of relevant 
studies included: 2 (1 
controlled BA, 1 



























S.S., Bougatsos, C., 




prevent child abuse 
and neglect: A 
systematic review 








Aim of the review: 
"To review new 



















lists of papers and, 
using Scopus, 








including study type, 
country: "We 









































of professionals; social 
work interventions; 
home visiting; parent 



























visits: one trial shows 
mixed results (sig effect 
at age 9 mo (I 2.2 mean 
visits, C 1.64), not at 1 y 
(I 2.44, C 2.0)) Current 
with immunizations: 
one trial shows no 
effect (I 93%, C 92%), 
one sig NR (I 77%, C 
87%) Delayed 
immunizations: one trial 
shows sig effect (I 3%, C 
10%) 
 
Results on inequalities: 




Sample sizes: 101-558 
 



















a focus on partner 
violence. Further 




Studies of older 








for reducing child 
abuse and neglect 
and related health 
outcomes, as well 








exposure to abuse or 
neglect or improve 
health outcomes. 
Studies were eligible 
for inclusion if they 
enrolled children 
without obvious signs 
or symptoms of abuse 
or neglect, used a 
method to identify 
families or children at 
risk that was 
applicable to primary 
care, evaluated an 
intervention that 
primary care clinicians 
could access or 
provide referral for, 
measured outcomes 








"We excluded studies 
focused on clinician 
education, methods 
to increase screening 
rates, and perceptions 
and attitudes of 
African 
American and 
living in poverty' 


















physicians and other 
clinicians, as well as 
studies of public 
awareness campaigns 
or other interventions 
not applicable to 
primary care settings 





Number of studies 
included: 11 RCTs 
 
Number of relevant 






















K.G., Jennings, A., 
Mayhew, A., et al., 
2011. The effects 
of on-screen, point 
of care computer 
reminders on 
processes and 
outcomes of care. 
Cochrane Database 
of Systematic 
Reviews. 1.  
 
Aim of the review: 





outcomes of care? 





















including study type, 







computer reminder to 
clinician at the point 
of care; Outcomes: 
Any process of care or 































validity score:  ̶ 
Intervention/s 
description: Computer 
reminders at the point 
of care to notify 
clinicians about 
eligibility for 
































Using median outcome 
from each study: 3.8% 
(0.5% to 6.6%) Using 
best outcome from each 
study: 4.8% (0.5% to 
7.8%) 
 






Attrition details: 11.1% 
and 19% for two 
studies; review authors 
report information 









content; use of 
median effect for 






Vaccination is not 
the main focus of 
the review. 
Limited data on 
context and 
population, and 
full outcome data 
are not reported 
for the studies 













opposed to generic 




users). 3. Do any 
readily identifiable 
















or other health 
professionals; 
Intervention: 
reminder not available 
within routinely used 
computer system 
 
Number of studies 
included: 28 RCTs 
 
Number of relevant 







s for future 
research: Factors 

















Chair in Patient 



























N.M., Sebaldt, R.J., 











of effects on 
process of care and 
patient outcomes. 
Implementation 
Science. 6. 87.  
 














ACP Journal Club, 
Database of Abstracts 
of Reviews of Effects 
(DARE), Cochrane 




































(N=3); one study 
reported to be 





































months - 2 











vaccine: one trial shows 
sig effect, two show no 
sig effect, one sig NR, 
one mixed. 
Pneumococcal vaccine: 
four trials show sig 
effect, two show no sig 
effect. Tetanus vaccine: 
two trials show sig 
effect. Up-to-date with 
vaccinations: one trial 
shows no sig effect. 
Correct vaccine 
decisions: one trial 
shows no sig effect 
Results on inequalities: 
No relevant data; one 
study presents 
subgroup analyses by 














so effects cannot 














review team: No 
major limitations. 
Vaccination is not 
the main focus of 
the study, and 
relevant 
outcomes are not 
clearly reported 





care or patient 
outcomes for PPC 
[primary 
preventive care], 
and what are the 
costs, safety, and 
provider 
satisfaction with 
CCDSS for PPC? 
 











Years searched: 1974 
- Jan 2010 (across all 




including study type, 
country: "We included 
RCTs (including cluster 
RCTs) published in any 
language that 
compared the effects 
of care with a CCDSS 
for PPC, used by 
healthcare providers, 
with care without a 
CCDSS. Outcomes 
included processes of 
care and patient 
outcomes. ... For PPC 
interventions, patients 
had to be free from 
the illness to be 
prevented (e.g., a 
specific strain of 
influenza) but could 










reported separately for 
studies with 
multiple 
outcomes / aims). 







s for future 
research: Data on 
adverse effects 















"CCDSSs that provided 
only computer-aided 
instruction, performed 
actions unrelated to 
clinical decision 
making (e.g., CCDSSs 
for diagnostic 
performance against a 
gold standard), or 
evaluated CCDSS 
users’ knowledge or 






merged with a 




those that did not 
focus on PPC (e.g., 
screening of medical 
errors)." (p3) 
 






Number of relevant 
































Aim of the review: 
To assess "the 
effects of 
vaccinating HCWs 




illness (ILI) and its 
complications in 







the Cochrane Acute 
Respiratory Infections 
Group’s Specialised 




Science Citation Index 














including study type, 
country: Population: 
HCWs, seniors ≥60; 
Intervention: influenza 

















homes for older 
people (mean 










validity score: + 
 
Intervention/s 
description: Policy of 
staff vaccination led by 
lead nurse, posters, 
leaflets, vaccination 
clinics; promotional 
campaign with posters 
and leaflets, plus face-
to-face meetings with 
all staff by researchers 
Control/comparison/s









months for one 
study, not 










Outcomes: In one 
study, I 570/1610 
vaccinated (35.4%), C 
84/1674 (5.0%); in the 
other, I 678/989 
(68.6%), C 323/1015 
(31.8%). Significance NR 
for this outcome. 
 















review team: The 
review question is 
tangential to ours; 
two studies 
happen to have 
relevant data 
reported, but 








s for future 
research: "We did 
not find studies 
that combined 
interventions and 






Review design: SR 








admissions and deaths 
from pneumonia in 
seniors cared for by 
vaccinated vs. non-
vaccinated HCWs; 
Study designs: RCT or 
non-randomised 
designs, all languages; 








Number of studies 
included: 5 (4 RCTs, 1 
cohort) 
 
Number of relevant 
studies included: 2 
cRCTs 





they “elect out”; 
rewards and 
incentives for 
HCWs to be 
vaccinated; 
handwashing; use 
of face masks; 
rapid detection of 
influenza cases in 
HCWs and 
patients by nasal 




visits by relatives 
and casual 
visitors; asking 
HCWs with ILI not 





such as COPD or 






































60 years and older 
in the community. 
Cochrane database 
of Systematic 
Reviews. 7.  
 
Aim of the review: 
"To assess effects 
of interventions to 
increase influenza 
vaccination rates 
in those 60 or 
older." (abstract) 
 
Review design: SR 















Web of Science Cited 




register of Clinical 
Trials; ProQuest 
Dissertations and 
Theses; contact with 



































Liiving in the 
community, 
seniors over 65, 
Intervention/s 
description: Client 
reminder and recall vs 
no intervention; 1.2. 
Tailored letter / phone 
call vs no intervention; 
1.3. Client reminder 
and recall (telephone 
call from senior plus 
educational brochure) 
compared to usual 
publicity; 1.4. Client 
reminder and recall 
(letter + leaflet) 
compared to letter; 
1.5. Client reminder 
and recall (customized 
letter) compared to 
form letter; 1.6. Client 
reminder and recall 
(telephone invitation) 
compared to invitation 
to patient when 
“dropped in” to clinic; 
1.7. Client-based 
education (nurses or 
pharmacists educated 
and nurses vaccinated 
patients) compared to 


























Outcomes: 1.1. Client 
reminder and recall vs 
no intervention (11 
RCTs): near-sig effect 
(OR 1.21 [0.99, 1.48]) 
1.2. Tailored letter / 
phone call vs no 
intervention (13 RCTs): 
sig effect (OR 1.53 [1.33, 
1.76]) 1.3. Client 
reminder and recall 
(telephone call from 
senior plus educational 
brochure) compared to 
usual publicity (1 RCT): 
sig effect (OR 3.33 [1.79, 
6.22]) 1.4. Client 
reminder and recall 
(letter + leaflet) 
compared to letter (1 
RCT): no sig diff (OR 
0.84 [0.26, 2.70]) 1.5. 
Client reminder and 
recall (customized 
letter) compared to 
form letter (1 RCT): no 
sig diff (OR 1.25 [0.39, 
4.04]) 1.6. Client 





































country: Study type: 
RCTs; Population: 
people aged 60 or 
over, living in 
institutions, 
temporarily in 
institutions such as 
emergency 
departments or 







access to services, 
provider- or system-
focused, or societal; 
Outcome: rates of 
vaccination, excluding 
studies with only self-
reported outcomes 
Exclusion criteria: 
Studies reporting only 
serological outcomes 
with no intervention 
to increase vaccination 
- Studies with only 
self-reported 
outcomes 
Number of studies 
seniors over 75, 
seniors over 65 





65 enrolled in 





persons over 65 













past 6 months, 
Medicare 
beneficiaries 




(health risk appraisal 
plus influenza 
vaccination) compared 
to no intervention; 1.9. 
Client-based education 
(nurses educated and 
vaccinated patients) 
compared to nurses 
educated patients; 2.1. 
Group visits of patients 
to physician and nurse 
compared to usual 
care; 2.2. Home visit 
compared to invitation 
to attend influenza 
vaccination clinic; 2.3. 




to home visit with 
safety intervention; 




vaccination, plus care 
plan developed with 
physician, compared to 
no intervention; 2.5. 
Free influenza vaccine 
compared to invitation 
compared to invitation 
to patient when 
“dropped in” to clinic (1 
RCT): sig effect (OR 2.72 
[1.55, 4.76]) 1.7. Client-
based education (nurses 
or pharmacists 
educated and nurses 
vaccinated patients) 
compared to no 
intervention (2 RCTs): 
sig effect (OR 3.29 [1.91, 
5.66]) 1.8. Client-based 
education (health risk 
appraisal plus influenza 
vaccination) compared 
to no intervention (1 
RCT): sig effect (OR 2.17 
[1.70, 2.77]) 1.9. Client-
based education (nurses 
educated and 
vaccinated patients) 
compared to nurses 
educated patients (1 
RCT): sig diff (OR 152.95 
[9.39, 2490.67]) 2.1. 
Group visits of patients 
to physician and nurse 
compared to usual care 
(1 RCT): sig effect (OR 
24.85 [1.45, 425.32]) 
2.2. Home visit 

















included: 44 (18 
cRCTs, 26 RCTs) 
 
Number of relevant 
studies included: 44 
(18 cRCTs, 26 RCTs) 
patients, ‘high-
risk’ patients, 














aged 65 or older 
with coronary 
heart disease, 









to be vaccinated but 
patient pays; 2.6. Free 
influenza vaccine 
compared to no 
intervention; 3.1. 
Reminder (to 
physician) compared to 
no reminder; 3.2. 
Reminder (to hospital 
staff to vaccinate 
patient) compared to 
letter to GP on day of 
discharge; 3.3. 
Reminder to physician 
about all patients 
compared to reminder 
about half patients; 
3.4. Posters in clinic 
displaying influenza 
vaccination rates to 
encourage doctors to 
compete, plus 
postcards to patients, 
compared to no 
intervention; 3.5. 
Posters in clinic 
displaying influenza 
vaccination rates to 
encourage doctors to 
compete, plus 
postcards to patients, 
compared to poster 
displaying vaccination 
to attend influenza 
vaccination clinic (2 
RCTs): sig diff (OR 1.30 





to home visit with 
safety intervention (1 
RCT): no diff (OR 0.98 
[0.64, 1.50]) 2.4. Home 
visit by nurse with 
encouragement to 
receive influenza 
vaccination, plus care 
plan developed with 
physician, compared to 
no intervention (1 RCT): 
sig eff (OR 8.15 [3.28, 
20.29]) 2.5. Free 
influenza vaccine 
compared to invitation 
to be vaccinated but 
patient pays (2 RCTs): 
sig eff (OR 2.36 [1.98, 
2.82]) 2.6. Free 
influenza vaccine 
compared to no 
intervention (2 RCTs): 
sig eff (OR 5.43 [2.85, 
10.35]) 3.1. Reminder 









compared to no 
intervention; 3.7. 
Educational reminders, 
academic detailing and 
peer comparisons to 
physicians compared to 
mailed educational 
materials; 3.8. Chart 




achieved by top 10% of 
physicians, compared 
to chart review and 
feedback; 3.9. 
Educational outreach + 
feedback to practice 
teams vs. written 
feedback to practice 
teams; 3.10. Payment 
to physicians  
 
Control/comparison/s
/ description: Most no 
intervention / usual 
care; some studies 
compare different 
to no reminder (3 RCTs): 
no sig eff (OR 1.28 
[0.73, 2.25]) 3.2. 
Reminder (to hospital 
staff to vaccinate 
patient) compared to 
letter to GP on day of 
discharge (1 RCT): no sig 
eff (OR 1.70 [0.51, 5.70 
]) 3.3. Reminder to 
physician about all 
patients compared to 
reminder about half 
patients (1 RCT): sig diff 
(OR 2.47 [1.53, 3.99]) 
3.4. Posters in clinic 
displaying influenza 
vaccination rates to 
encourage doctors to 
compete, plus postcards 
to patients, compared 
to no intervention (1 
RCT): sig eff (OR 2.03 [ 
1.86, 2.22 ]) 3.5. Posters 
in clinic displaying 
influenza vaccination 
rates to encourage 
doctors to compete, 
plus postcards to 
patients, compared to 
poster displaying 
vaccination rates (1 




types of intervention 
(e.g. different formats 
of reminder) 
 






to no intervention (3 
RCTs): no sig eff (OR 
5.51 [0.56, 53.78]) 3.7. 
Educational reminders, 
academic detailing and 
peer comparisons to 
physicians compared to 
mailed educational 
materials (1 RCT): no sig 
diff (OR 1.13 [0.80, 
1.58]) 3.8. Chart review 




achieved by top 10% of 
physicians, compared to 
chart review and 
feedback (1 RCT): sig 
diff (OR 3.43 [ 2.37, 4.97 
]) 3.9. Educational 
outreach + feedback to 
practice teams vs. 
written feedback to 
practice teams (1 RCT): 
sig less eff (OR 0.77 




Payment to physicians 
(2 RCTs): sig eff (OR 2.22 
[ 1.77, 2.77 ]) 
 
Results on inequalities: 










Attrition details: Not 
fully reported (attrition 
not reported if ITT 





















C. & Osborn, D.A. 
2012. Home visits 
during pregnancy 
and after birth for 
women with an 





Reviews. 1.  
 
Aim of the review: 
"To determine the 
effects of home 
visits during 
pregnancy and/or 
after birth for 
women with a 











Childbirth Group Trials 
Register (which 
includes hand 








chasing; contact with 
experts 
 
Years searched: 1966 




including study type, 
country: Study 




















in one study (NR 








In one study, 
women using 
illegal drugs (no 
Intervention/s 
description: Regular 
home visits by 
midwives, who gave 
advice on a range of 
health / parenting 
issues and links to 
other services 
Control/comparison/s
/ description: In one 
study, controls had a 
telephone contact at 2 
months and a home 
visit at 6 months; in the 



























significant difference in 
incomplete vaccination 
schedule at six months 
(pooled RR 1.09, 95% CI 
0.91 to 1.32) 
 
Results on inequalities: 
Not reported 
specifically, although 
populations of both 
studies were likely 
disadvantaged 
 
Sample sizes: 136-154 
mother-infant pairs (for 
relevant studies) 
Attrition details: One 
study 5% I, 12% C; the 












review team: No 
methodological 
limitations. 
Vaccination is not 
the main focus of 






s for future 
research: Further 














with alcohol or drug 
problem (defined as 80 
g/day alcohol or binge 
drinking, any illicit drug 
use, or prescription 
drug abuse); 
Intervention: home 
visits by doctors, 
nurses, social workers, 
counsellors or trained 
lay people; Outcome: 





child health status and 
health service use, 
child educational and 
psychosocial 
outcomes, maternal 
health status, health 





Number of studies 




the other study, 
pregnant 
women aged 
<18, who had 
high rates of 
alcohol (69-79%) 




















Number of relevant 






















N., Woodward, H., 
Majeed, A., et al. 









Reports. 2(10), 81.  
 
Aim of the review: 




















contact with experts, 




Inception to June 2010 
 
Inclusion criteria, 
including study type, 
country: RCT, nRCT, 
BA or ITS studies; 
children <5 years; 
‘developed' countries; 
studies reporting the 
increase in the 
proportion of the 
target population who 

































Reminder and recall 
(mainly postal / 
telephone reminders); 
2. Parental education; 
3. Patient-held records; 
4. Provider-based 
interventions, incl. 
bonuses / enhanced 
fees, reminders, 
various forms of 
educational or training 
interventions, or 
changes to services 
(e.g. walk-in clinics) 
 
Control/comparison/s

























interventions (N=22). Of 
RCTs (N=19), 6 show sig 
positive effect 
(comparative effect 
sizes 8%-24%), 4 no sig 
effect, 7 mixed effects, 
and 2 sig NR. Of nRCTs 
(N=3), 2 show sig 
positive effect, 1 no sig 
effect. "Fourteen (34%) 
of the 41 intervention 
arms showed a 
statistically significant (P 
< 0.05) increase in 
immunisation rates [i.e. 
within-group] ... Overall, 
these studies reported a 
median point change of 
11% (mean 10%, range 
–11% to 24%)." 2. 
Parental education 
(N=2). Both studies 
show no sig effect. 3. 
Patient-held records 
(N=1). No sig effect. 4. 
Provider-based 
interventions (N=13). Of 

















and limitations of 
the evidence 


























Number of studies 
included: 46 (26 RCTs, 
11 BAs, 9 controlled 
intervention trials) 
 
Number of relevant 
studies included: 46 








Not all provide 
information 
other than age 
(range between 
birth - 5y), but 
of those that 
















validity score: + 
 
 
mixed results, 2 no 
effect, and 1 sig NR. Of 
nRCTs (N=4), 2 show sig 
positive effect, 1 no 
effect, and 1 sig NR. Of 
one-group studies 
(N=4), 3 show sig 
positive effect, 1 no 
effect. Overall, median 
[within-group?] change 
reported as 7% for 
provider 
reminder/recall, 8% for 
provider education, and 
19% for feedback. 5. 
Multi-component 
interventions (N=8). 
One nRCT shows no sig 
effect. Of one-group 
studies (N=7), 3 show 
sig positive effect, 4 sig 
NR. Overall median 
[within-group?] change 
reported as 15%. 
 
Results on inequalities: 
Not clearly reported. 
Several studies did 
target low-SES and/or 
BME population 
 
Sample sizes: Mostly 

















are reported range 222-
3,015 
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10 Appendix 4. Quality appraisal example 
 
Study identification Arditi, C., Rège-Walther, M., Wyatt, 
J.C., Durieux, P., Burnand, B., 2012. 
Computer-generated reminders 
delivered on paper to healthcare 
professionals: Effects on 
professional practice and health 
care outcomes. Cochrane Database 
of Systematic Reviews.  
Guidance topic Tuberculosis: clinical diagnosis and 
management of tuberculosis, and 
measures for its prevention and 
control (update) 
Checklist completed by Theo Lorenc 
SCREENING QUESTIONS 
In a well-conducted systematic review: In this review this criterion is met 
(yes, no, unclear): 
1 Does the review address an appropriate and clearly-
focused question that is relevant to 1 or more of the 
guidance topic’s key research question/s? 
No 
Vaccination is not a main focus of 
this review 
2 Does the review include types of study/s relevant to the 
key research question/s? 
Yes 
Included RCTs and nRCTs 
3 Is the literature search sufficiently rigorous to identify 
all the relevant studies? 
Yes 
Reasonably sensitive terms and 
range of sources 
4 Is the study quality of included studies appropriately 
assessed and reported? 
Yes 
Cochrane ‘risk of bias’ tool 
5 Is an adequate description of the analytical 
methodology used included, and are the methods used 
appropriate to the question? 
Yes 
Synthesis well described and 
appropriate 
 
 
